AMERICAN MEDICAL SECURITY GROUP INC
8-K, 1998-09-30
HOSPITAL & MEDICAL SERVICE PLANS
Previous: FIRST TRUST COMBINED SERIES 144, 485BPOS, 1998-09-30
Next: AMERICAN MEDICAL SECURITY GROUP INC, 424B3, 1998-09-30




                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 --------------

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

      Date of Report (Date of earliest event reported): SEPTEMBER 25, 1998


                      AMERICAN MEDICAL SECURITY GROUP, INC.
             (Exact name of Registrant as specified in its charter)


         WISCONSIN                     1-13154                  39-1431799
(State of Incorporation)       (Commission File Number)      (I.R.S. Employer 
                                                             Identification No.)

3100 AMS BOULEVARD, GREEN BAY, WISCONSIN                                54313
(Address of principal executive offices)                              (Zip Code)

                                 (920) 661-1111
              (Registrant's telephone number, including area code)


                         United Wisconsin Services, Inc.
            401 West Michigan Street, Milwaukee, Wisconsin 53203-2896
                        (Former name and former address)

                                 --------------

<PAGE>


         ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS.

THE DISTRIBUTION

     On September 25, 1998 (the "Distribution  Date"),  the Registrant  effected
the distribution  (the  "Distribution")  of shares of common stock, no par value
per share (the "Distributed  Shares" or the "Newco Common Stock"), of its wholly
owned subsidiary  Newco/UWS,  Inc. ("Newco"),  a Wisconsin  corporation,  to the
Registrant's shareholders. Each shareholder was entitled to receive one share of
Newco Common Stock for each share of common stock of the Registrant ("Registrant
Common Stock") owned at the close of business on September 11, 1998 (the "Record
Date"). The Distribution resulted in all of the issued and outstanding shares of
Newco Common Stock being  distributed to holders of shares of Registrant  Common
Stock on a pro rata basis. On or about the Distribution  Date, the Company began
to mail  certificates  evidencing  shares of Newco  Common  Stock to  holders of
shares of Registrant  Common Stock. No  consideration  is required of holders of
shares of  Registrant  Common Stock in return for the  Distributed  Shares.  The
Registrant has received a ruling from the Internal Revenue Service to the effect
that the Distribution will qualify as a tax-free distribution to the Registrant,
Newco and the Registrant's shareholders for federal income tax purposes.

     In connection with the Distribution, the Registrant's name was changed from
United Wisconsin Services, Inc. to American Medical Security Group, Inc. ("AMSG"
or the  "Company"),  and Newco  was  renamed  United  Wisconsin  Services,  Inc.
("UWS").  Newco  is a  newly  formed  corporation  which,  as a  result  of  the
transactions  entered into in  connection  with the  Distribution,  now owns the
businesses  and assets of, and is  responsible  for the  liabilities  associated
with,  the health  maintenance  organization  (HMO)  managed care and  specialty
products   businesses  and  management   business  formerly   conducted  by  the
Registrant.  AMSG  continues  to  own  the  businesses  and  assets  of,  and is
responsible for the liabilities  associated with, the  Registrant's  small group
business described in the Registrant's Annual Report on Form 10-K for the fiscal
year ended December 31, 1997.

     Following  the  Distribution,  AMSG does not own any shares of Newco Common
Stock, and Newco does not own any shares of AMSG Common Stock. Immediately after
the  Distribution,  Blue Cross & Blue Shield United of Wisconsin  ("Blue Cross")
owned  38.1% of the  outstanding  shares of AMSG  Common  Stock and 38.1% of the
outstanding  shares of Newco Common  Stock.  The shares of Newco (now named UWS)
Common Stock are listed on the New York Stock Exchange ("NYSE") under the symbol
"UWZ." The shares of  Registrant  (now named AMSG) Common  Stock  continue to be
listed on the NYSE, but are now listed under the symbol "AMZ."

BUSINESS OF THE COMPANY

     AMSG, based in Green Bay, Wisconsin,  intends to concentrate its efforts on
continuing to develop,  market and administer  small group medical and specialty
insurance  products and  administrative  services for small groups.  The Company
offers a wide  variety of health  care  insurance  products  including  medical,
dental, prescription drug, life insurance and disability. The Company's products
are sold through  approximately  38,000 independent licensed agents in 33 states
and the District of Columbia. More than 145 Company sales managers located at 70
offices throughout the U.S. support the agents. As of June 30, 1998, the Company
served approximately 578,000 medical members.

     The  Company  specializes  in  providing  health-care  benefits  and  other
insurance   products  designed  to  maximize  choice  and  control  costs  in  a
compassionate  environment.  The  Company  principally  markets  health  benefit
products  that provide  discounts to insureds  that utilize  preferred  provider
organizations  (PPOs).  PPO plans  differ from HMO plans in that they  typically
provide a wider choice of health  professionals,  fewer benefit restrictions and
increased  access to  specialists  at a  somewhat  higher  price.  AMSG owns two
preferred provider networks through which  approximately 22% of its business was
conducted  as of June  30,  1998.  It also  contracts  with  more  than 65 other
networks to ensure cost-effective health care choices for its customers.

     The Company's  health benefit  products are targeted to groups of two to 99
employees.  The Company can customize  employee  benefit packages for businesses
and  individuals by providing  benefit  options which allow  businesses to offer
employees multiple medical plans in a single package.  In addition,  the Company
offers a wide range of voluntary  benefits  providing  protection beyond medical
coverage.  These voluntary  benefits  include group life,  dental and short-term
disability.  Optional services  available include a workplace wellness incentive
program,  administrative  services for groups subject to COBRA  regulation,  and
Section 125 plans that allows employees to set aside funds on a pretax basis for
unreimbursed medical and dependent care expenses. Self-funded plans that provide
employers with the opportunity to customize  benefits for their  employees,  are
offered to groups of 25 to 99 employees.  The Company also provides coverage for
individuals  and families that can be customized to fit various  lifestyles  and
budgets.

BUSINESS STRATEGY

     The Company  believes that the heart of the national  health care debate is
consumer  demand  for  broader  choices  and  increased  access to  health  care
providers.  As a specialist in providing  and  underwriting  PPO  products,  the
Company  believes  that  it can  capitalize  on the  growing  demand  for  these
products.  According to recent  reports of the U.S.  Department  of Census,  the
small business  market in which the Company  markets its products is the fastest
growing  segment  of the U.S.  economy.  While  the small  business  market is a
rapidly  growing  market,  the Company also  believes  that the primary  factors
affecting the Company's profitability are the management of medical expenses and
the control of its expense ratio through scale and  operational  efficiency.  To
achieve its goal of becoming a  multi-billion  dollar  company and the  nation's
foremost  small group,  managed care  company,  AMSG has developed the following
business strategies:

            -  DEVELOP  INTERNAL  GROWTH.  Through its independent  agents,  the
              Company  will  continue  to offer a wide  range  of  competitively
              priced products  emphasizing  choice and flexible  benefits,  with
              excellent  customer service support 24 hours per day, 365 days per
              year.

            -  CONTAIN  MEDICAL  LOSS RATIO.  The  Company  plans to contain its
              medical loss ratio through  pricing and product design  reflective
              of ultimate  claims costs.  Actions taken to support this strategy
              include  exiting  certain  unprofitable  markets  in states  where
              regulations   preclude   meeting   this   standard,    terminating
              unprofitable   business,   and   implementing   appropriate   rate
              increases.

            -  LEVERAGE  EXPENSE  RATIO.  The Company  intends to  leverage  its
              expense ratio by increasing  its business in force at its existing
              facility in Green Bay,  Wisconsin and by  increasing  productivity
              through process re-engineering and automation efforts.

            -  GROW  THROUGH  ACQUISITIONS.  Growth  through  acquisitions  will
              continue  as a core  strategy.  The  Company  plans to continue to
              leverage  its expense  ratio  advantage  and its  expertise in the
              small group segment to acquire  books of business  during a period
              of industry consolidation. In 1997, the Company acquired the small
              group business of Pan-American Life Insurance Company. It acquired
              the balance of Pan-American's  domestic health benefit business in
              July 1998.

MANAGEMENT

     AMSG will be managed  by  substantially  the same  senior  management  that
managed  American  Medical  Security  Holdings,  Inc.  ("AMS"),  a wholly  owned
subsidiary of the Registrant, prior to the Distribution.  After the Distribution
Date, the Company's Board of Directors  consists of three continuing  directors,
two of whom were also directors of AMS and six new directors,  five of whom were
also directors of AMS.

     Subsequent to the Distribution, the executive officers of the Company
are as follows:

     SAMUEL V.  MILLER,  CHAIRMAN OF THE BOARD,  PRESIDENT  AND CHIEF  EXECUTIVE
OFFICER.  Mr. Miller joined the Company in 1995 as an Executive Vice  President.
He became a Director,  President and CEO of AMS in 1996 and was elected Chairman
of AMS  earlier  this year.  From 1994 to 1996,  Mr.  Miller was a member of the
executive staff planning group with the Travelers Group, serving as Chairman and
Group  Chief  Executive  of National  Benefit  Insurance  Company and  Primerica
Financial  Services Ltd. of Canada.  Prior to 1994, Mr. Miller spent 10 years as
President and CEO of American Express Life Assurance Company.  From 1976 to 1984
Mr. Miller  served as Senior Vice  President of Sales and Marketing at Employers
Health Insurance  Company,  now the small group business of Humana,  Inc. He was
one of the builders of Employers Health Insurance Company where he later took on
additional  responsibility  as chief operating  officer and led Employers Health
Insurance Company's sale to American Express.

     EDWARD R. SKOLDBERG,  EXECUTIVE VICE PRESIDENT AND CHIEF OPERATING OFFICER.
Mr.  Skoldberg  joined AMS in 1996 in his present  capacity.  He has 25 years of
financial, technical and operational experience, the last 10 years in the health
insurance  industry.  Prior  to  joining  AMS,  Mr.  Skoldberg  held  management
positions  with Time  Insurance,  Empire Blue Cross Blue  Shield,  City  Federal
Savings & Loan, and Howard Savings Bank.

     GARY D. GUENGERICH,  EXECUTIVE VICE PRESIDENT,  CHIEF FINANCIAL OFFICER AND
TREASURER.  Mr. Guengerich  joined AMS in 1997 in his present  capacity.  He has
more than 23 years of financial management experience in the insurance industry.
Before joining AMS, Mr. Guengerich held senior  management  positions with First
Colony Life Insurance Company, American Life Insurance Company and Colonial Penn
Group.

     TIMOTHY J. MOORE,  SENIOR VICE  PRESIDENT,  GENERAL  COUNSEL AND  CORPORATE
SECRETARY. Mr. Moore joined AMS in 1997 in his present capacity. He has 25 years
of  insurance  experience  and is  admitted  to practice  law in  Wisconsin  and
Illinois.  Prior to joining  AMS,  he was a partner in the  Chicago  law firm of
Katten,  Muchin & Zavis.  He has also held positions  with Insurance  Company of
Illinois, Underwriters Adjusting Company and Southwestern Adjusting Company.

     CLIFFORD  A.  BOWERS,  VICE  PRESIDENT,  CORPORATE  COMMUNICATIONS.  Before
joining  AMS  in  1997  in  his  present   capacity,   Mr.  Bowers  held  senior
communications  positions  with Fort Howard,  Tenneco,  Manville  and  Brunswick
Corporations.

     SCOTT B. WESTPHAL,  VICE PRESIDENT AND CHIEF ACTUARY. Mr. Westphal has held
various  management  positions  with AMS since its inception in 1988, and has 15
years of experience as an actuary.  Before  joining AMS, he worked for Employers
Health Insurance Company.

     JOHN R. WIRCH, VICE PRESIDENT HUMAN RESOURCES AND CORPORATE  SERVICES.  Mr.
Wirch joined AMS in 1996 in his present capacity. Prior to joining AMS, he spent
18 years in various  human  resources  management  positions  with Little Rapids
Corporation, Presto Products and Universal Foundry.

     Subsequent  to  the  Distribution,  the  Directors  of the  Company  are as
follows:

     CLASS I - TERM EXPIRING AT ANNUAL MEETING OF SHAREHOLDERS IN 1999

     ROGER  H.  BALLOU.  Mr.  Ballou  has been the  Chairman  and CEO of  Global
Vacation  Group since March 1998.  Immediately  prior to that time,  Mr.  Ballou
served as a senior  advisor to Thayer  Capital  Partners.  Between  May 1995 and
September 1997, Mr. Ballou served as Vice Chairman and Chief  Marketing  Officer
and then as President and Chief Operating Officer of Alamo Rent-a-Car.  For more
than 16 years  prior  to  joining  Alamo,  Mr.  Ballou  held  several  executive
positions  with American  Express  Travel,  serving most recently as President -
Travel Services Group.

     W. FRANCIS  BRENNAN.  Mr. Brennan is a retired  Executive Vice President of
UNUM Corporation, an insurance holding company, where he served on the boards of
UNUM's insurance affiliates in the United States, Canada, the United Kingdom and
Japan.  Before  joining  UNUM in 1984,  he spent 21 years in a variety of senior
management  positions  with  CIGNA  Corporation  and  Connecticut  General  Life
Insurance  Company.  He is a Director  of Margent  Group,  Inc.,  a  reinsurance
holding  company with  operations in the United  States,  the United Kingdom and
Bermuda.

     J. GUS SWOBODA. Mr. Swoboda is a retired Senior Vice President of Human and
Corporate Development of Wisconsin Public Service Corporation where he also held
various  other senior  management  positions  in his long career with  Wisconsin
Public  Service.  He is a Director of First  Northern  Capital Corp., a publicly
traded financial institution operating in Northeast Wisconsin.

     CLASS II - TERM EXPIRING AT ANNUAL MEETING OF SHAREHOLDERS IN 2000

     JAMES C.  HICKMAN.  Mr.  Hickman has been a Director  of the Company  since
1991.  He is also  currently  a Director  of Blue Cross and  Century  Investment
Management Company. In addition,  Mr. Hickman has been an Emeritus Professor and
Emeritus Dean of the School of Business at the  University of  Wisconsin-Madison
("UW School of  Business")  since July 1993. He was a Professor in the UW School
of Business  from 1990 to 1993,  and was Dean of the UW School of Business  from
1985 to 1990.

     WILLIAM R.  JOHNSON.  Mr.  Johnson has been a Director of the Company since
1993.  In addition,  he has been  Chairman of Johansen  Capital  Investment  and
Financial  Consulting since 1986, and President of Johansen Capital  Associates,
Inc., a financial and  investment  consultant to  corporations  and  individuals
since 1984.  He was also  Chairman,  President  and Chief  Executive  Officer of
National Investment Services of America, Inc., an investment manager of pension,
profit sharing, and other funds, from 1968 to 1984.

     FRANK SKILLERN.  Mr. Skillern has been Chief Executive  Officer of American
Express  Centurion Bank, a consumer bank located in Salt Lake City,  Utah, since
1995.  From 1993 to 1995 he was President,  Consumer Card Group,  USA,  American
Express Travel Related Services  Company ("TRS"),  having served as an Executive
Vice President of TRS for the prior two years.  Mr. Skillern was general counsel
of American Express Financial  Advisors (then IDS Financial  Services) from 1983
to 1991. Prior to that time, he practiced law with several  prominent laws firms
and  spent  time  as  general  counsel  of  the  Federal  Depository   Insurance
Corporation.

     CLASS III - TERM EXPIRING AT ANNUAL MEETING OF SHAREHOLDERS IN 2001

     EUGENE A. MENDEN. Mr. Menden has been a Director of the Company since 1991.
He was a  Director  of Blue  Cross  from  January  1987  until  1992.  Prior  to
retirement,  he was a Director of  International  Finance for Marquette  Medical
Systems, Inc. (formerly Marquette Electronics,  Inc.), a manufacturer of medical
electronic  products.  He also served as Vice President of Finance for Marquette
Electronics,  Inc. from 1970 to 1991, as Treasurer  from 1970 to 1989,  and as a
director from 1972 until June 1996.

     SAMUEL V. MILLER. See officer description above.

     MICHAEL T. RIORDAN.  Mr. Riordan was President and Chief Operating  Officer
of Fort James Corporation,  Deerfield, Illinois from 1997 to 1998. Prior to that
time, he was Chairman, President and CEO of Fort Howard Corporation which merged
with James  River  Corporation  in 1997 to become  Fort James  Corporation.  Mr.
Riordan held various senior management positions with Fort Howard since 1983. He
is also a director of the Dial Corporation.

     After the  Distribution,  the  Company  and Newco  will have  three  common
directors,  Messrs.  Menden,  Hickman and Johnson.  Messrs.  Menden, Hickman and
Johnson,  as well as certain  other  officers  and  directors of the Company and
Newco, also will own shares in both companies following the Distribution.

DIVIDEND POLICY

     The Company does not expect to pay any cash  dividends  in the  foreseeable
future following the Distribution. The Company intends to employ its earnings in
the continued  development  of its  business.  The future  dividend  policy will
depend on the Company's earnings, capital requirements,  financial condition and
other factors considered relevant by the Board of Directors.

ADDITIONAL INFORMATION

     Further  information  concerning the  Distribution  and related  matters is
contained   in  the   Registration   Statement  on  Form  10,  as  amended  (the
"Registration Statement"), filed with the Securities and Exchange Commission and
the NYSE by Newco to register the Newco Common Stock  pursuant to Section  12(b)
of the  Securities  Exchange  Act of 1934,  as amended,  and in the  Information
Statement of Newco,  dated  September 11, 1998,  filed with and  incorporated by
reference  in  the  Registration  Statement.   The  Distribution  and  Indemnity
Agreement  entered  into by Newco  and the  Registrant  in  connection  with the
Distribution,  a Tax  Allocation  Agreement,  Employee  Benefits  Agreement  and
various  other  agreements  with respect to employee  benefits,  management  and
corporate and administrative services, reinsurance arrangements and intellectual
property  transfers,  for the purpose of giving effect to the  Distribution  and
related  matters,  are described in and/or filed as exhibits to the Registration
Statement.

FORWARD-LOOKING STATEMENTS

     This report contains certain forward-looking statements with respect to the
financial  condition,  results of  operations  and business of the Company.  The
terms  "anticipate",   "believe",  "estimate",  "expert",  "objective",  "plan",
"project"  and similar  expressions  are  intended  to identify  forward-looking
statements.  Such  forward-looking  statements are subject to inherent risks and
uncertainties  that may cause actual results or events to differ materially from
those  contemplated  by such  forward-looking  statements.  In  addition  to the
assumptions  and other factors  referred to specifically in connection with such
statements, factors that may cause actual results or events to differ materially
from  those  contemplated  by such  forward-looking  statements  include,  among
others,  rising health care costs,  business  conditions and  competition in the
managed care industry,  developments in health care reform and other  regulatory
issues, and other factors that may be referred to in the Company's reports filed
with the Securities and Exchange Commission from time to time.

     ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

     (b) PRO FORMA FINANCIAL INFORMATION:

          The following unaudited pro forma consolidated financial statements of
     AMSG and subsidiaries, reflecting the Distribution, are filed herewith:

          Pro Forma Consolidated Balance Sheet as of June 30, 1998

          Pro Forma  Consolidated  Statements of Income for the Six Months Ended
     June 30, 1998 and the Year Ended December 31, 1997

          Notes to the Pro Forma Consolidated Financial Information

     (c) EXHIBITS:

          See the Exhibit Index  following  the  Signature  page of this report,
     which is incorporated herein by reference.


<PAGE>



                      AMERICAN MEDICAL SECURITY GROUP, INC.
                                    PRO FORMA
                       CONSOLIDATED FINANCIAL INFORMATION
                                   (Unaudited)

     The following  unaudited pro forma  consolidated  financial  information is
based on the historical  consolidated  financial  statements of American Medical
Security Group, Inc., formerly United Wisconsin  Services,  Inc. (the "Company")
and gives effect to the  distribution of Newco/UWS,  Inc. to the shareholders of
the Company.

     The  unaudited  Pro Forma  Consolidated  Balance  Sheet as of June 30, 1998
presents the  financial  position of the Company  assuming the  distribution  of
Newco/UWS,  Inc. had been  completed as of that date.  The  unaudited  Pro Forma
Consolidated  Statements  of Income for the six month period ended June 30, 1998
and the year ended  December 31, 1997 present the results of  operations  of the
Company  assuming that the  distribution  had been completed on January 1 of the
respective  period.  In the  opinion  of  management,  the  unaudited  pro forma
financial information includes all material adjustments necessary to restate the
Company's   historical  results.   The  adjustments  required  to  reflect  such
assumptions  are described in Note 2 of the Notes to the Pro Forma  Consolidated
Financial Information.

     The unaudited pro forma consolidated  financial  information should be read
in conjunction with the historical  consolidated  financial statements and notes
thereto in the Company's 1997 Annual Report. The pro forma information presented
is for information  purposes only and may not necessarily reflect future results
of  operations  or  financial  position  or what the  results of  operations  or
financial position would have been had the distribution  actually taken place at
the beginning of the period or as of the dates specified.

<PAGE>
<TABLE>



                                               AMERICAN MEDICAL SECURITY GROUP, INC.

                                               PRO FORMA CONSOLIDATED BALANCE SHEET
                                                            (Unaudited)

<CAPTION>

                                                                                                  June 30, 1998
                                                                              ------------------------------------------------------

                                                                                                    Pro Forma
                                                                               Historical          Adjustments           Pro Forma

                                                                              ------------------------------------------------------
                                                                                                 (000'S OMITTED)
<S>                                                                           <C>                 <C>                   <C>
ASSETS

Investments:
     Securities available for sale, at fair value:
        Fixed maturities.................................................       $275,949                   $-             $275,949
        Equity securities - common.......................................         15,728                    -               15,728
        Equity securities - preferred....................................          2,515                    -                2,515
     Fixed maturity securities held to maturity, at amortized cost.......          3,928                    -                3,928
                                                                              ------------         ------------         ------------
          Total investments..............................................        298,120                    -              298,120

Cash and cash equivalents................................................          7,078                    -                7,078

Other assets:
     Property and equipment, net.........................................         36,839                    -               36,839
     Goodwill and other intangibles, net.................................        134,557                    -              134,557
     Other assets........................................................         25,412                    -               25,412
                                                                              ------------         ------------         ------------
          Total other assets.............................................        196,808                    -              196,808

Net assets of discontinued operations....................................        126,194             (126,194)                   -
                                                                              ------------         ------------         ------------

TOTAL ASSETS.............................................................       $628,200            $(126,194)            $502,006
                                                                              ============         ============         ============


LIABILITIES AND SHAREHOLDERS' EQUITY

Liabilities:
     Medical and other benefits payable..................................       $102,422                   $-             $102,422
     Advance premiums....................................................         20,038                    -               20,038
     Payables and accrued expenses.......................................         20,401                    -               20,401
     Notes payable.......................................................        126,013              (70,000)              56,013
     Other liabilities...................................................         30,157                    -               30,157
                                                                              ------------         ------------         ------------
          Total liabilities..............................................        299,031              (70,000)             229,031

Shareholders' equity:
     Common stock........................................................         16,570                    -               16,570
     Paid-in capital.....................................................        188,428                    -              188,428
     Retained earnings...................................................        121,021              (54,947)              66,074
     Unrealized gain on investments......................................          3,150               (1,247)               1,903
                                                                              ------------         ------------         ------------
          Total shareholders' equity.....................................        329,169              (56,194)             272,975
                                                                              ------------         ------------         ------------

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY...............................       $628,200            $(126,194)            $502,006
                                                                              ============         ============         ============




See Notes to the Pro Forma Consolidated Financial Information
</TABLE>

<PAGE>
<TABLE>



                                                 AMERICAN MEDICAL SECURITY GROUP, INC.
                                              PRO FORMA CONSOLIDATED STATEMENTS OF INCOME
                                                              (Unaudited)

<CAPTION>


                                                              Six months ended                         Twelve months ended
                                                                June 30, 1998                           December 31, 1997
                                                   ---------------------------------------   ---------------------------------------
                                                                  Pro Forma                                 Pro Forma
                                                   Historical    Adjustments    Pro Forma    Historical    Adjustments    Pro Forma
                                                   ---------------------------------------   ---------------------------------------
                                                                        (000'S OMITTED, EXCEPT PER SHARE DATA)
<S>                                                <C>           <C>           <C>           <C>           <C>           <C>
Revenues:

     Insurance premiums........................     $461,915            $-      $461,915    $1,518,886     $(561,682)     $957,204
     Net investment results....................       11,804             -        11,804        46,308       (22,237)       24,071
     Other revenue.............................        9,475             -         9,475        50,088       (25,839)       24,249
                                                   -----------   -----------   -----------   -----------   -----------   -----------
        Total Revenues.........................      483,194             -       483,194     1,615,282      (609,758)    1,005,524

Expenses:

     Medical and other benefits................      353,610             -       353,610     1,220,052      (486,561)      733,491
     Selling, general and administrative.......      116,735             -       116,735       344,650       (92,490)      252,160
     Profit sharing on joint ventures..........            -             -             -         3,381        (3,381)            -
     Interest expense..........................        4,707        (2,433)        2,274         9,311        (4,892)        4,419
     Amortization of goodwill and intangibles..        4,435                       4,435         8,793          (818)        7,975
                                                   -----------   -----------   -----------   -----------   -----------   -----------
        Total Expenses.........................      479,487        (2,433)      477,054     1,586,187      (588,142)      998,045
                                                   -----------   -----------   -----------   -----------   -----------   -----------

Income From Continuing Operations
     Before Income Taxes.......................        3,707         2,433         6,140        29,095       (21,616)        7,479

Income Tax Expense.............................        1,764           852         2,616        10,945        (8,201)        2,744
                                                   -----------   -----------   -----------   -----------   -----------   -----------
Net Income From Continuing Operations..........       $1,943        $1,581        $3,524       $18,150      $(13,415)       $4,735
                                                   ===========   ===========   ===========   ===========   ===========   ===========


Net Income From Continuing Operations
Per Common Share:

     Basic.....................................        $0.12                       $0.21         $1.11                         $0.29
     Diluted...................................        $0.12                       $0.21         $1.10                         $0.29
                                                                                                         


See Notes to the Pro Forma Consolidated Financial Information
</TABLE>

<PAGE>


                      AMERICAN MEDICAL SECURITY GROUP, INC

            NOTES TO THE PRO FORMA CONSOLIDATED FINANCIAL INFORMATION
                                   (Unaudited)

NOTE 1.

     The accompanying  unaudited Pro Forma  Consolidated  Financial  Information
reflects all adjustments which, in the opinion of management,  are necessary for
fair presentation of the company's financial position and results of operations.
This information does not include certain  disclosures  required under generally
accepted  accounting  principles and,  therefore,  should be read in conjunction
with the Company's historical financial statements and notes thereto.

NOTE 2.

     The pro forma adjustments to the accompanying  financial  information as of
and for the six months ended June 30, 1998 are as follows:

               To record the  distribution  of $70  million in long term debt to
          Newco/UWS,  Inc.,  the  debt and  related  interest  expense  has been
          eliminated.  The income tax impact for this adjustment is estimated at
          a rate of 35%.

               To reflect the  distribution of net assets of Newco/UWS,  Inc. to
          the Company's  shareholders,  "Net assets of discontinued  operations"
          has been eliminated.  This amount,  less the long term debt assumed by
          Newco/UWS,  Inc.  (as  described  above),  has  been  reflected  as  a
          reduction of retained earnings and unrealized gains on investments.

     The pro forma adjustments to the accompanying financial information for the
year ended December 31, 1997 are described as follows:

               Adjustments  to remove  results of operations of Newco/UWS,  Inc.
          from the Company's historical statement of income.

               Interest expense on long term debt distributed to Newco/UWS, Inc.
          (as described above) and the related income tax impact at 35% has been
          eliminated.

NOTE 3.

     Basic and diluted per share  information is based upon historical  weighted
average common shares outstanding for the six months ended June 30, 1998 and the
year ended  December  31,  1997,  respectively.  Diluted  per share  information
differs  from  basic per share data due to  potentially  dilutive  common  stock
options held by officers and employees of both  Newco/UWS,  Inc. and the Company
and other parties.  The number of shares under option and their exercise  prices
of each companies'  common stock  subsequent to the  distribution  date is based
upon the  market  value  of each  company's  shares  immediately  following  the
distribution as described in the Newco/UWS,  Inc. Registration Statement on Form
10, as amended. The number of common shares and potentially dilutive shares used
to compute  earnings per share after the  distribution is not known at this time
and may vary from the historical reported earnings per share.

<PAGE>

                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                           AMERICAN MEDICAL SECURITY GROUP, INC.




Dated: September 30, 1998                  /s/ Timothy J. Moore  
       ------------------                  --------------------
                                           Timothy J. Moore
                                           Senior Vice President

<PAGE>
<TABLE>


                                       AMERICAN MEDICAL SECURITY GROUP, INC.
                                      (F/K/A UNITED WISCONSIN SERVICES, INC.)
                                           (COMMISSION FILE NO. 1-13154)
<CAPTION>

                                                   EXHIBIT INDEX
                                                        TO
                                              FORM 8-K CURRENT REPORT
                                        Date of Report: September 25, 1998

<S>                  <C>                                    <C>                                       <C>    
                                                            INCORPORATED HEREIN                       FILED
EXHIBIT NO.          DESCRIPTION                            BY REFERENCE TO                           HEREWITH

2.1                  Distribution and Indemnity Agreement   Exhibit 2.1 to Newco/UWS, Inc.'s
                     between United Wisconsin Services,     Registration Statement on Form 10,
                     Inc. and Newco/UWS, Inc., dated as     as amended (the "Registration
                     of September 11, 1998                  Statement") (File No. 1-14177)

2.2                  Employee Benefits Agreement, dated     Exhibit 10.1 to the Registration
                     as of September 11, 1998, by and       Statement
                     between United Wisconsin Services,
                     Inc. and Newco/UWS, Inc.

2.3                  Tax Allocation Agreement, entered      Exhibit 10.2 to the Registration
                     into as of September 11, 1998, by      Statement
                     and between United Wisconsin
                     Services, Inc. and Newco/UWS, Inc.

3.1                  Restated and Amended Articles of                                                     X
                     Incorporation of American Medical
                     Security Group, Inc. (f/k/a United
                     Wisconsin Services, Inc.), as
                     amended through September 28, 1998

3.2                  Bylaws of American Medical Security                                                  X
                     Group, Inc. (f/k/a United Wisconsin
                     Services, Inc.), as amended and
                     restated through September 25, 1998

99.1                 Information Statement of Newco/UWS,    Exhibit 99 to the Registration
                     Inc., dated September 11, 1998         Statement.

99.2                 Press Release dated September 29,                                                    X
                     1998
</TABLE>



                                                                     EXHIBIT 3.1
COMPOSITE COPY


                              RESTATED AND AMENDED
                            ARTICLES OF INCORPORATION
                                       OF
                      AMERICAN MEDICAL SECURITY GROUP, INC.
                     (AS AMENDED THROUGH SEPTEMBER 28, 1998)


     These Articles of  Incorporation  are executed by the  undersigned  for the
purpose of  amending  and  superseding  the  corporate  charter  of a  Wisconsin
corporation authorized pursuant to Chapter 180 of the Wisconsin Statutes.

                      ARTICLE I - NAME AND PRINCIPAL OFFICE

     The name of the corporation shall be AMERICAN MEDICAL SECURITY GROUP, INC.

                              ARTICLE II - PURPOSES

     The  purposes  of this  Corporation  are to engage in any  lawful  activity
within the purposes for which  corporations may be organized under the Wisconsin
Business Corporation Law, Chapter 180 of the Wisconsin Statutes.

                           ARTICLE III - CAPITAL STOCK

     a. The  aggregate  number  of  authorized  shares  of  Common  Stock of the
Corporation  shall be Fifty  Million  (50,000,000)  shares,  designed as "Common
Stock", and having no par value per share.

     b. The  aggregate  number of  authorized  shares of Preferred  Stock of the
Corporation  shall  be Five  Hundred  Thousand  (500,000)  shares,  designed  as
"Preferred Stock", and having no par value per share. Authority is hereby vested
in the Board of  Directors  from time to time to issue  the  Preferred  Stock as
Preferred Stock in one or more series of any number of shares and, in connection
with the creation of each such series,  to fix, by resolution  providing for the
issue  of  shares  thereof,   the  voting  rights,  if  any;  the  designations,
preferences,  limitations  and relative  rights of such series in respect to the
rate of dividend, the price, the terms and conditions of redemption; the amounts
payable upon such series in the event of voluntary or  involuntary  liquidation;
sinking fund provisions for the redemption or purchase of such series of shares;
and, if the shares of any series are issued with the  privilege  of  conversion,
the terms and  conditions  on which such series of shares may be  converted.  In
addition to the  foregoing,  to the full extent now or  hereafter  permitted  by
Wisconsin law, in connection with each issue thereof, the Board of Directors may
at its discretion  assign to any series of the Preferred Stock such other terms,
conditions,  restrictions,  limitations,  rights and  privileges  as it may deem
appropriate. The aggregate number of preferred shares issued and not canceled of
any and all  preferred  series  shall not exceed  the total  number of shares of
Preferred Stock hereinabove authorized.  Each series of Preferred Stock shall be
distinctively designated by letter or descriptive words or both.

     Pursuant  to the  authority  expressly  granted  and vested in the Board of
Directors  of the  Corporation  and in  accordance  with the  provisions  of the
Restated and Amended Articles of Incorporation,  as amended as of July 31, 1991,
the Board of Directors  hereby  designates  25,000  shares of the  Corporation's
authorized and unissued  Preferred  Stock,  no par value per share,  as Series A
Adjustable Rate  Nonconvertible  Preferred Stock, $1,000 stated value per share,
which shall have the following  powers,  designations,  preferences and relative
participating, optional or other special rights and qualifications,  limitations
or restrictions:

     SECTION 1.  DESIGNATION  AND  AMOUNT.  The shares of such  series  shall be
designated as the "Series A Adjustable Rate Nonconvertible  Preferred Stock" and
the number of shares  constituting  such series  shall be Twenty  Five  Thousand
(25,000),  which  number,  subject  to the  Restated  and  Amended  Articles  of
Incorporation, may be increased or decreased by the Board of Directors without a
vote of the shareholders;  PROVIDED,  HOWEVER,  such number may not be decreased
below the number of the then currently outstanding shares of Series A Adjustable
Rate  Nonconvertible  Preferred  Stock  plus the  number of  shares  that may be
reserved for issuance upon the exercise of any options,  warrants,  or rights or
upon the  conversion of any  outstanding  securities  issued by the  Corporation
convertible into Series A Adjustable Rate  Nonconvertible  Preferred Stock. Upon
the issuance of any shares of Series A Adjustable Rate Nonconvertible  Preferred
Stock,  an amount  equal to the  aggregate  stated value of the shares so issued
will be assigned to the capital of the Corporation representing such shares.

     SECTION 2.  FRACTIONAL  SHARES.  The  Corporation  may issue  fractions and
certificates  representing  fractions  of a share of  Series A  Adjustable  Rate
Nonconvertible  Preferred  Stock in  integral  multiples  of one  one-thousandth
(1/1000) of a share of Series A Adjustable Rate Nonconvertible  Preferred Stock.
In the event that fractional  shares of Series A Adjustable Rate  Nonconvertible
Preferred  Stock are  issued,  the  holders  thereof  shall  have all the rights
provided  herein  for  holders  of full  shares  of  Series  A  Adjustable  Rate
Nonconvertible  Preferred Stock in the proportion which such fraction bears to a
full share.

     SECTION 3. VOTING RIGHTS.  Except as required by law,  holders of shares of
Series A Adjustable Rate  Nonconvertible  Preferred Stock shall have no right to
vote.

     SECTION  4.  CONVERSION  OR  EXCHANGE.  The  holders  of shares of Series A
Adjustable  Rate  Nonconvertible  Preferred  Stock  shall  not have any right to
convert  such shares into or exchange  such shares for shares of any other class
or classes or any other  series of any class or classes of capital  stock of the
Corporation.

     SECTION 5. DIVIDENDS.

          A. When and as declared  by the Board of  Directors,  the  Corporation
     shall pay, out of any funds legally available for the payment of dividends,
     cumulative  cash  dividends  to the  holders  of the  shares  of  Series  A
     Adjustable Rate Nonconvertible Preferred Stock from the date of issuance as
     provided in this  paragraph.  The  dividend  rate on the shares of Series A
     Adjustable Rate  Nonconvertible  Preferred Stock shall be fixed on a yearly
     basis ("Yearly Dividend Period") and shall be payable quarterly, out of any
     funds legally available for the payment of dividends,  in cash on March 31,
     June 30,  September  30 and December 31 in each year  ("Quarterly  Dividend
     Period").  The dividend rate for each Yearly Dividend Period,  payable each
     Quarterly  Dividend Period in that year, shall be at a rate per annum equal
     to the Applicable  Rate (as defined in Section 5(B)).  Such dividends shall
     be cumulative from the date of original issuance of such shares of Series A
     Adjustable Rate Nonconvertible  Preferred Stock and shall be payable out of
     funds  legally  available  therefor,  when and as  declared by the Board of
     Directors  in March,  June,  September  and  December  of each  year.  Such
     dividends will accrue whether or not they have been declared and whether or
     not there are funds of the Corporation legally available for the payment of
     dividends. Each of such dividends shall be paid to the holders of record of
     shares of Series A Adjustable Rate  Nonconvertible  Preferred Stock as they
     appear on the stock  register  of the  Corporation  on such  record date as
     shall be fixed by the Board of  Directors  or a  committee  of the Board of
     Directors duly authorized to fix such date. Dividends on account of arrears
     (accrued but not declared) for any past  Quarterly  Dividend  Period may be
     declared and paid at any time,  without  reference to any regular  dividend
     payment  date,  to  holders  of  record on such date as may be fixed by the
     Board of Directors or a committee of the Board of Directors duly authorized
     to fix such date. If at any time the  Corporation  pays less than the total
     amount of  dividends  then  accrued  with respect to the shares of Series A
     Adjustable  Rate  Nonconvertible  Preferred  Stock,  such payment  shall be
     distributed   ratably  among  the  holders  of  Series  A  Adjustable  Rate
     Nonconvertible  Preferred Stock based upon the aggregate accrued but unpaid
     dividends on the shares held by each such holder.

          B. The  "Applicable  Rate" for any Yearly Dividend Period shall be the
     Treasury Bill Rate plus 150 basis points. The "Treasury Bill Rate" for each
     Yearly  Dividend  Period shall be the weekly per annum market discount rate
     for  one-year  U.S.  Treasury  bills,  as  published  weekly by the Federal
     Reserve  Board,  during the last full week in the month of September in the
     year prior to the Yearly  Dividend  Period for which the Applicable Rate is
     being  determined.  In the event the Federal Reserve Board does not publish
     such a weekly per annum market  discount  rate for one-year  U.S.  Treasury
     bills during the last full week in the month of September in the year prior
     to the  Yearly  Dividend  Period  for  which the  Applicable  Rate is being
     determined, then the Applicable Rate shall mean the weekly per annum market
     discount rate for one-year U.S.  Treasury bills as published  weekly by any
     Federal  Reserve  Bank  or by any  U.S.  Government  department  or  agency
     selected  by the  Corporation,  during  the last  full week in the month of
     September  in the year  prior to the Yearly  Dividend  Period for which the
     Applicable  Rate  is  being  determined.   In  the  event  the  Corporation
     determines  in good faith that for any  reason no such U.S.  Treasury  bill
     rates are  published  as  provided  above  during the last full week in the
     month of  September  in the year  prior to the Yearly  Dividend  Period for
     which the Applicable  Rate is being  determined,  then the Applicable  Rate
     shall be the average  weekly per annum  market  discount  rate for one-year
     U.S.  Treasury  bills,  as quoted to the  Corporation by a recognized  U.S.
     Government  securities dealer selected by the Corporation.  Anything herein
     to the  contrary  notwithstanding,  the  Applicable  Rate  for  any  Yearly
     Dividend Period shall in no event be less than 7.00% or greater than 10.00%
     per annum.

          C. The Applicable  Rate shall be rounded to the nearest one thousandth
     (1/1000) of a percentage point.

          D. Dividends  payable on the Series A Adjustable  Rate  Nonconvertible
     Preferred  Stock for each full Quarterly  Dividend Period shall be computed
     by annualizing the Applicable Rate and dividing by four and multiplying the
     quotient  so  obtained  by the  stated  value  per  share  of the  Series A
     Adjustable Rate  Nonconvertible  Preferred Stock.  Dividends payable on the
     Series A Adjustable Rate Nonconvertible Preferred Stock for any period less
     than a full Quarterly  Dividend  Period shall be computed on the basis of a
     360-day year of 30-day  months and the actual number of days elapsed in the
     period for which dividends are payable.

          E.  Holders  of  shares  of Series A  Adjustable  Rate  Nonconvertible
     Preferred Stock shall not be entitled to any dividends,  whether payable in
     cash,  property or stock,  in excess of full  cumulative  dividends  on the
     Series A Adjustable Rate Nonconvertible Preferred Stock as provided in this
     Section 5. Accrued but unpaid  dividends  shall not bear  interest,  and no
     interest, or sum of money in lieu of interest,  shall be payable in respect
     of any  dividend  payment  or  payments  on the  Series A  Adjustable  Rate
     Nonconvertible Preferred Stock which may be in arrears.

          F. Anything herein to the contrary  notwithstanding,  dividends may be
     declared and paid upon any of the equity securities of the Corporation even
     if all accrued  dividends  on the Series A Adjustable  Rate  Nonconvertible
     Preferred Stock have not yet been declared and/or paid in full.

     SECTION 6. LIQUIDATION. Upon any liquidation,  dissolution or winding up of
the Corporation,  whether voluntary or involuntary,  the holders of the Series A
Adjustable  Rate  Nonconvertible  Preferred  Stock will be  entitled to be paid,
whether from capital or surplus, before any distribution or payment is made upon
the then  outstanding  shares of Common Stock or any other class of stock of the
Corporation  ranking  junior  to the  Series A  Adjustable  Rate  Nonconvertible
Preferred  Stock upon  liquidation,  an amount in cash equal to the stated value
of,  together with all accrued but unpaid  dividends on, the Series A Adjustable
Rate Nonconvertible Preferred Stock (the "Liquidation Price"). To the extent any
accrued  dividends  have not  been  paid by the  Corporation  as of the date the
Corporation  pays to the  holders  of the  shares  of Series A  Adjustable  Rate
Nonconvertible  Preferred  Stock the  Liquidation  Price  hereunder,  and to the
extent the Corporation has at that time funds legally  available for the payment
of  dividends,  the  Board  of  Directors  shall,  prior to the  payment  of the
Liquidation Price, declare and cause such dividends to be paid. If upon any such
liquidation,  dissolution,  or winding up of the Corporation,  the Corporation's
assets to be distributed  among the holders of the shares of Series A Adjustable
Rate  Nonconvertible  Preferred Stock are insufficient to permit payment to such
holders of the  aggregate  amount which they are  entitled to be paid,  then the
entire assets to be distributed  will be distributed  ratably among such holders
based upon the aggregate  Liquidation Price of the shares of Series A Adjustable
Rate  Nonconvertible  Preferred Stock held by each such holder.  Upon receipt of
the  aggregate  Liquidation  Price for each  share of Series A  Adjustable  Rate
Nonconvertible  Preferred  Stock,  holders of shares of Series A Adjustable Rate
Nonconvertible  Preferred  Stock shall have no further  rights to participate in
any liquidation, dissolution or winding up of the Corporation.

     SECTION  7.  RANKING OF CLASSES  OF STOCK.  The  Series A  Adjustable  Rate
Nonconvertible  Preferred  Stock  shall rank  junior to all other  series of the
Corporation's   Preferred   Stock  as  to  the  payment  of  dividends  and  the
distribution of assets in liquidation, unless the terms of any such series shall
provide  otherwise.  Nothing  contained  herein  shall be deemed to restrict the
ability of the Corporation to create and issue  additional  classes or series of
its Preferred  Stock or other capital stock ranking senior or junior to, or on a
parity with, the Series A Adjustable Rate  Nonconvertible  Preferred Stock as to
the payment of  dividends or the  distribution  of assets upon  liquidation,  or
both.  Specifically,  any stock of any class or classes of the Corporation shall
be deemed to rank:

               i. prior to the shares of Series A Adjustable Rate Nonconvertible
          Preferred Stock,  either as to dividends or upon  liquidation,  if the
          holders of such class or classes  shall be  entitled to the receipt of
          dividends or of amounts distributable upon dissolution, liquidation or
          winding up of the Corporation, as the case may be, in preference of or
          in  priority  to the  holders  of shares of Series A  Adjustable  Rate
          Nonconvertible Preferred Stock;

               ii.  on  a  parity  with  shares  of  Series  A  Adjustable  Rate
          Nonconvertible  Preferred  Stock,  either  as  to  dividends  or  upon
          liquidation, whether or not the dividend rates, dividend payment rates
          or  redemption  or  liquidation  prices  per  share  or  sinking  fund
          provisions,  if  any,  are  different  from  those  of  the  Series  A
          Adjustable Rate Nonconvertible Preferred Stock, if the holders of such
          stock  shall be entitled  to the  receipt of  dividends  or of amounts
          distributable  upon  dissolution,  liquidation  or  winding  up of the
          Corporation,  as the case may be, in  proportion  to their  respective
          dividend rates or liquidation prices,  without preference or priority,
          one over the  other,  as  between  the  holders  of such stock and the
          holders of shares of Series A Adjustable Rate Nonconvertible Preferred
          Stock; and

               iii. junior to shares of Series A Adjustable Rate  Nonconvertible
          Preferred Stock,  either as to dividends or upon liquidation,  if such
          class  shall be Common  Stock or if the  holders of shares of Series A
          Adjustable  Rate  Nonconvertible  Preferred Stock shall be entitled to
          receipt of dividends  or of amounts  distributable  upon  dissolution,
          liquidation or winding up of the  Corporation,  as the case may be, in
          preference  of or  priority  to the holders of shares of such class or
          classes.

     SECTION 8. REDEMPTION OF SHARES.

          A. The shares of Series A  Adjustable  Rate  Nonconvertible  Preferred
     Stock shall be subject to the following redemption rights:

               i. At any  time or from  time  to time  following  issuance,  the
          Corporation,  at its option,  may redeem shares of Series A Adjustable
          Rate  Nonconvertible   Preferred  Stock  in  whole  or  in  part.  The
          redemption  price  per share in such  event  shall be paid in cash and
          shall be equal to the greater of the following:  (aa) $1,000,  plus in
          each case an amount  equal to accrued  (whether or not  declared)  and
          unpaid  dividends  to  the  redemption  date  (out  of  funds  legally
          available therefor); or (bb) the fair market value per share as of the
          end of the quarter  preceding the quarter  during which the redemption
          is to occur,  as determined in good faith by the Board of Directors in
          accordance   with  a  written   appraisal  which  is  prepared  by  an
          independent  appraiser  selected  by the  Board  and  which  meets the
          requirements  of applicable law. Upon the date of notice to the holder
          of shares of Series A Adjustable Rate  Nonconvertible  Preferred Stock
          of the Corporation's  election to redeem shares,  notwithstanding that
          any  certificates  for  such  shares  have not  been  surrendered  for
          cancellation,  the shares of Series A Adjustable  Rate  Nonconvertible
          Preferred  Stock  represented   thereby  shall  no  longer  be  deemed
          outstanding,  the rights to receive  dividends  thereon shall cease to
          accrue  from and after the date of notice and all rights of the holder
          of shares so redeemed  shall cease and  terminate,  excepting only the
          right to receive the redemption price therefor; and

               ii. The  Corporation  shall redeem  shares of Series A Adjustable
          Rate  Nonconvertible  Preferred Stock which are beneficially  owned by
          any of  its  employees,  or  employees  of  any  of the  Corporation's
          Affiliates,  pursuant to the  Corporation's  or any of its Affiliates'
          employees  pre-tax  savings  plans (the "401(k)  Plans"),  immediately
          prior  to any  distribution  or  withdrawal  of  shares  of  Series  A
          Adjustable Rate Nonconvertible  Preferred Stock from any of the 401(k)
          Plans for any reason.  For purposes of this Section 8, an  "Affiliate"
          of the Corporation  means a "person" that directly,  or through one or
          more intermediaries, controls, or is controlled by, or is under common
          control with, the Corporation,  and a "person" means an individual,  a
          corporation,  a partnership,  an associate,  a joint-stock  company, a
          business trust or an unincorporated organization. The redemption price
          per  share in such  event  shall be paid in cash and shall be equal to
          the greater of the following: (aa) $1,000, plus in each case an amount
          equal to accrued (whether or not declared) and unpaid dividends to the
          redemption date (out of funds legally available therefor); or (bb) the
          fair market value per share as of the end of the quarter preceding the
          quarter during which the redemption is to occur, as determined in good
          faith by the Board of Directors in accordance with a written appraisal
          which is prepared by an  independent  appraiser  selected by the Board
          and  which  meets  the  requirements  of  applicable  law.  Upon  such
          attempted  withdrawal,  notwithstanding that any certificates for such
          shares  have not been  surrendered  for  cancellation,  the  shares of
          Series A Adjustable Rate  Nonconvertible  Preferred Stock  represented
          thereby shall no longer be deemed  outstanding,  the rights to receive
          dividends  thereon  shall  cease to accrue  from and after the date of
          attempted  withdrawal and all rights of the employee as a holder shall
          cease  and  terminate,   excepting  only  the  right  to  receive  the
          redemption  price therefor.  In the event the Corporation is unable to
          redeem  all such  shares of Series A  Adjustable  Rate  Nonconvertible
          Preferred  Stock upon the occurrence of such an attempted  withdrawal,
          the  obligation  of the  Corporation  to so  redeem  pursuant  to this
          subparagraph (ii) shall continue and funds legally available  therefor
          shall be applied for such purpose until such obligation is discharged.

          B. Anything herein to the contrary notwithstanding, in accordance with
     Section 180.0640 of the Wisconsin Business Corporation Law, the Corporation
     may not redeem shares of Series A Adjustable Rate Nonconvertible  Preferred
     Stock  pursuant to Section 8(A) (i) or (ii) if, after giving  effect to the
     redemption, either of the following would occur:

               i. The  Corporation  would  not be able to pay its  debts as they
          become due in the usual course of business; or

               ii. The Corporation's  total assets would be less than the sum of
          its total  liabilities  plus the amount  that would be needed,  if the
          Corporation  were to be  dissolved at the time of the  redemption,  to
          satisfy the preferential rights upon dissolution to shareholders whose
          preferential rights are superior to those of the holders of the Series
          A Adjustable Rate Nonconvertible Preferred Stock.

     SECTION  9.  REACQUIRED  SHARES.  Any  shares of Series A  Adjustable  Rate
Nonconvertible Preferred Stock redeemed or otherwise acquired by the Corporation
in any manner  whatsoever  shall be retained  and  canceled  promptly  after the
redemption or acquisition thereof. All such shares shall upon their cancellation
become  authorized but unissued shares of Preferred Stock and may be reissued as
part of a new series of Preferred  Stock which may be created by  resolutions of
the Board of Directors.

     SECTION  10. NO  SINKING  FUND.  The  shares of  Series A  Adjustable  Rate
Nonconvertible Preferred Stock are not subject or entitled to the operation of a
retirement or sinking fund.

               ARTICLE IV - REGISTERED OFFICE AND REGISTERED AGENT

     The registered office is 3100 AMS Boulevard,  Green Bay, Wisconsin,  54313,
and the registered agent at such address is Timothy J. Moore.

                         ARTICLE V - BOARD OF DIRECTORS

     a. The number of  directors of the  Corporation  shall be as is provided in
the bylaws.  The general powers,  number,  classification,  and requirements for
nomination  of  directors  shall be as set forth in  Articles  II and III of the
bylaws of the Corporation  (and as such sections shall exist from time to time).
The Board of  Directors  of the  Corporation  shall be  divided  into  three (3)
classes of not less than three (3) nor more than five (5)  directors  each.  The
term of office of the first class of directors  shall expire at the first annual
meeting after their initial election under the provisions of this Article V, the
term of office of the second  class shall  expire at the second  annual  meeting
after their  initial  election  under the  provisions of this Article V, and the
term of office of the third class shall expire at the third annual meeting after
their initial  election  under the  provisions of this Article V. At each annual
meeting after the initial  classification  of the Board of Directors  under this
Article  V, the  class  of  Directors  whose  term  expires  at the time of such
election  shall be  elected to hold  office  until the third  succeeding  annual
meeting.

     b. A director  may be removed  from office only by  affirmative  vote of at
least 80% of the  outstanding  shares  entitled to vote for the election of such
director, taken at an annual meeting or a special meeting of shareholders called
for that  purpose,  and any vacancy so created may be filled by the  affirmative
vote of at least 80% of such shares.

     c.  Notwithstanding  any other  provision  of these  Restated  Articles  of
Incorporation (and  notwithstanding  the fact that a lesser affirmative vote may
be specified by law), the affirmative  vote of shareholders  possessing at least
75 % of the voting power of the then outstanding  shares of all classes of stock
of the Corporation generally possessing voting rights in elections of directors,
considered  for this  purpose as one class,  shall be required to amend,  alter,
change or repeal,  or adopt any provision  inconsistent  with, the provisions of
this Article V.

     d.  Notwithstanding  the  foregoing  and  provisions  in the  bylaws of the
Corporation,  whenever the holders of any one or more series of Preferred  Stock
issued by the Corporation  pursuant to Article III hereof have the right, voting
separately as a class or by series,  to elect  directors at an annual or special
meeting of shareholders,  the election, term of office, filling of vacancies and
other  features  of such  directorships  shall be  governed  by the terms of the
series of Preferred  Stock  applicable  thereto,  and such  directors so elected
shall not be divided into classes unless expressly  provided by the terms of the
applicable series.

                             ARTICLE VI - AMENDMENTS

     These articles may be amended in the manner  provided by law at the time of
adoption of the amendment.



                                                                     EXHIBIT 3.2


                                    BYLAWS OF
                      AMERICAN MEDICAL SECURITY GROUP, INC.
                  (AS AMENDED AND RESTATED SEPTEMBER 25, 1998)


                               ARTICLE I. OFFICES

     SECTION 1. PRINCIPAL AND BUSINESS  OFFICES.  The  Corporation may have such
principal  and other  business  offices,  either  within or without the State of
Wisconsin,  as the Board of  Directors  may  designate or as the business of the
Corporation may require from time to time.

     SECTION 2.  REGISTERED  OFFICE.  The registered  office of the  Corporation
required by the Wisconsin Business Corporation Law to be maintained in the State
of Wisconsin may be, but need not be,  identical to the principal  office in the
state of Wisconsin; and the address of the registered office may be changed from
time to time by the Board of Directors or by the registered  agent. The business
office of the  registered  agent of the  Corporation  shall be  identical to the
registered office.

                            ARTICLE II. SHAREHOLDERS

     SECTION 1. ANNUAL MEETING.  The Annual Meeting of the Shareholders shall be
held at the principal  office of the Corporation in the City of Green Bay, Brown
County,  Wisconsin,  unless  the  Board of  Directors  shall  designate  another
location  either  within or without the State of Wisconsin.  The Annual  Meeting
shall take place on the last Thursday of May each year or at such other time and
date as may be fixed by or under the authority of the Board of Directors. If the
day  fixed  for the  Annual  Meeting  shall be a legal  holiday  in the State of
Wisconsin,  such meeting shall be held on the next  succeeding  business day. At
such meeting the  Shareholders  shall elect  directors  and transact  such other
business as shall lawfully come before them.

          A. ELECTIONS AND OTHER  BUSINESS.  Nominations of persons for election
     to the Board of Directors of the  Corporation  and the proposal of business
     to be considered by the Shareholders may be made at the Annual Meeting:

               1. Pursuant to the Corporation's notice of meeting;

               2. By or at the direction of the Board of Directors; or

               3. By any  Shareholder of the Corporation who is a shareholder of
          record at the time of the giving of the notice  provided  for in these
          Bylaws and who is entitled to vote at the  meeting and  complies  with
          the notice procedures set forth below.

          B. NOMINATIONS AND SUBMISSION OF BUSINESS MATTERS.  For nominations or
     other  business  to be  properly  brought  before  an Annual  Meeting  by a
     Shareholder,  the  Shareholder  must have given  timely  notice  thereof in
     writing to the Secretary of the  Corporation.  Timely notice is that notice
     which is received by the Secretary at the  Corporation's  principal  office
     not less than 60 days nor more than 90 days  prior to the date on which the
     Corporation  first mailed its proxy  materials  for the prior year's Annual
     Meeting,  provided,  however,  that in the  event  the  date of the  Annual
     Meeting  is  advanced  by more than 30 days or delayed by more than 60 days
     from the last  Thursday in May,  notice by the  Shareholder,  to be timely,
     must be received as provided  above not earlier  than the 90th day prior to
     the date of such Annual Meeting and not later than the close of business on
     the later of (x) the 60th day prior to such Annual Meeting, or (y) the 10th
     day on which  public  announcement  of the date of such a meeting  is first
     made.  Such  Shareholder's  notice  shall be signed by the  Shareholder  of
     record who intends to make the  nomination or introduce the other  business
     (or his or her duly authorized proxy or other  representative),  shall bear
     the date of signature of such Shareholder or representative,  and shall set
     forth:

               1. The name and  address,  as they  appear  on the  Corporation's
          books,  of such  Shareholder and the beneficial  owner(s),  if any, on
          whose behalf the nomination or proposal is made;

               2. The class and  number of shares of the  Corporation  which are
          beneficially owned by such Shareholder or beneficial owner(s);

               3. A  representation  that such Shareholder is a holder of record
          of shares  entitled  to vote at such  meeting and intends to appear in
          person or by proxy at the meeting to make the  nomination or introduce
          the other business specified in the notice;

               4.  In the  case  of any  proposed  nomination  for  election  or
          reelection as a director:

                    (a) the name and residence address of the nominee;

                    (b) a  description  of all  arrangements  or  understandings
               between such Shareholder or beneficial  owner(s) and each nominee
               and any other person(s) (naming such person(s)) pursuant to which
               the nomination is to be made by the Shareholder;

                    (c) such other  information  regarding each nominee proposed
               by such  Shareholder  as would be  required  to be  disclosed  in
               solicitations of proxies for elections of directors,  or would be
               otherwise  required  to be  disclosed,  in each case  pursuant to
               Regulation  14A under the  Securities  Exchange  Act of 1934,  as
               amended,  including any information  that would be required to be
               included in a proxy  statement  filed  pursuant to Regulation 14A
               had the nominee been nominated by the Board of Directors; and

                    (d) the  written  consent  of each  nominee to be named in a
               proxy  statement and to serve as a director of the Corporation if
               so elected; and

               5. In the  case  of any  other  business  that  such  Shareholder
          proposes to bring before the meeting,

                    (a) a  brief  description  of  the  business  desired  to be
               brought  before the  meeting,  and,  if the  business  includes a
               proposal  to amend these  Bylaws,  the  language of the  proposed
               amendment;

                    (b) such  Shareholder's and beneficial  owner's(s')  reasons
               for conducting such business at such time; and

                    (c)  any  material   interest  in  such   business  of  such
               Shareholder or beneficial owners(s).

                    Notwithstanding  anything  in  the  above  paragraph  to the
               contrary, in the event that the number of directors to be elected
               to the Board of Directors of this  Corporation  is increased  and
               there is no public  announcement  naming all of the  nominees for
               director  or  specifying  the  size  of the  increased  Board  of
               Directors  made by the  Corporation at least 70 days prior to the
               last Wednesday in May, a  Shareholder's  notice  required by this
               Section shall also be considered timely, but only with respect to
               nominees for new  positions  created by such  increase,  if it is
               received by the Secretary at the  Corporation's  principal office
               not later than the close of  business  on the 10th day  following
               the day on which such  public  announcement  is first made by the
               Corporation.

     SECTION 2. SPECIAL  MEETINGS.  Special  meetings of the Shareholders may be
called by the  Chairman of the Board,  and shall be called by the  Secretary  on
written  request of a  majority  of  members  of the Board of  Directors,  or on
written  request of the  holders  of at least 10  percent  of the  Corporation's
shares  entitled  to vote on a matter.  The request  shall be signed,  dated and
delivered to the Secretary describing one or more purposes for which the meeting
is to be held. The Board of Directors shall set the place of the meeting.  If no
such  designation  is made,  the  place of the  meeting  shall be the  principal
business  office of the  Corporation in the State of Wisconsin,  but any meeting
may be adjourned to reconvene at any place designated by a vote of a majority of
the shares represented thereat.

          A. ELECTIONS AND OTHER  BUSINESS.  Nominations of persons for election
     to the  Board  of  Directors  may be made at a  Special  Meeting  at  which
     directors are to be elected pursuant to such notice of meeting:

               1. By or at the direction of the Board of Directors; or

               2. By any Shareholder of the Corporation who:

                    (a) is a Shareholder  of record at the time of giving notice
               of the meeting,

                    (b) is entitled to vote at the meeting, and

                    (c) complies with the notice procedures set forth below.

          B. NOMINATIONS AND SUBMISSION OF BUSINESS MATTERS.  Only such business
     as shall have been  described  in such  notice  shall be  conducted  at the
     Special Meeting.  Any Shareholder desiring to nominate persons for election
     to the Board of Directors at a Special  Meeting shall cause written  notice
     to be received by the Secretary of the Corporation at its principal  office
     not earlier than 90 days prior to such  Special  Meeting and not later than
     the  close of  business  on the  later  of (x) the  60th day  prior to such
     Special  Meeting  or (y) the 10th  day  following  the day on which  public
     announcement  is first made of the date of such Special  Meeting and of the
     nominees  proposed by the Board of Directors to be elected at such meeting.
     Such  written  notice  shall be signed  by the  Shareholder  of record  who
     intends  to make the  nomination  (or his or her duly  authorized  proxy or
     other representative), shall bear the date of signature of such Shareholder
     or other representative, and shall set forth:

               1. The name and  address,  as they  appear  on the  Corporation's
          books,  of such  Shareholder and the beneficial  owner(s),  if any, on
          whose behalf the nomination is made;

               2. The class and  number of shares of the  Corporation  which are
          beneficially owned by such Shareholder or beneficial owner(s);

               3. A  representation  that such Shareholder is a holder of record
          of shares of the  Corporation  entitled  to vote at such  meeting  and
          intends  to appear in  person or by proxy at the  meeting  to make the
          nomination specified in the notice;

               4.  The  name  and  residence  address  of  the  person(s)  to be
          nominated;

               5. A description of all  arrangements or  understandings  between
          such Shareholder or beneficial owner(s) and each nominee and any other
          person(s) (naming such person(s))  pursuant to which the nomination is
          to be made by such Shareholder;

               6. Such other information regarding each nominee proposed by such
          Shareholder as would be required to be disclosed in  solicitations  of
          proxies for elections of directors,  or would be otherwise required to
          be  disclosed,  in each  case  pursuant  to  Regulation  14A under the
          Securities Exchange Act of 1934, as amended, including any information
          that would be  required  to be  included  in a proxy  statement  filed
          pursuant to Regulation 14A had the nominee been nominated by the Board
          of Directors; and

               7. The  written  consent  of each  nominee to be named in a proxy
          statement and to serve as a director of the Corporation if so elected.

     SECTION 3. NOTICE OF ANNUAL OR SPECIAL MEETING.  Notice may be communicated
by   telegraph,   teletype,   facsimile  or  other  form  of  wire  or  wireless
communication,  or by mail or private  carrier,  and, if these forms of personal
notice are  impracticable,  notice may be communicated  by public  announcement.
Such  notice  stating the place,  day and hour of the meeting  and, in case of a
special meeting,  a description of each purpose for which the meeting is called,
shall be communicated or sent not less than 10 days nor more than 60 days before
the date of the meeting,  by or at the direction of the Chairman of the Board or
the  Secretary,  or other  Officer  or  persons  calling  the  meeting,  to each
shareholder  of record  entitled to vote at such meeting.  Written notice by the
Corporation to its shareholders is effective when mailed and may be addressed to
the  shareholder's   address  shown  in  the  Corporation's  current  record  of
shareholders.

     SECTION 4. UNANIMOUS CONSENT WITHOUT MEETING.  Any action that may be taken
at a meeting of the  Shareholders may be taken without a meeting if a consent in
writing  setting  forth  the  action  so  taken  shall be  signed  by all of the
Shareholders entitled to vote with respect to the subject matter thereof.

     SECTION 5.  CLOSING OF STOCK  TRANSFER  BOOKS OR FIXING OF RECORD  DATE.  A
"Shareholder" of the Corporation  shall mean the person in whose name shares are
registered in the stock  transfer  books of the  Corporation  or the  beneficial
owner of shares to the extent of the rights granted by a nominee  certificate on
file with the Corporation. Such nominee certificates, if any, shall be reflected
in the stock transfer books of the  Corporation.  For the purpose of determining
Shareholders  entitled to notice of or to vote at any meeting of Shareholders or
any  adjournment  thereof,  or  Shareholders  entitled to receive payment of any
dividend,  or in order to make a  determination  of  Shareholders  for any other
proper purpose, the Board of Directors may provide that the stock transfer books
shall be closed for a stated period but not to exceed,  in any case, 70 days. If
the  stock  transfer  books  shall be  closed  for the  purpose  of  determining
Shareholders  entitled to the notice of or to vote at a meeting of Shareholders,
such  books  shall be closed  for at least 10 days  immediately  preceding  such
meeting. In lieu of closing the stock transfer books, the Board of Directors may
fix in  advance  a date  as the  record  date  for  any  such  determination  of
Shareholders,  such date in any case to be not more than 70 days and, in case of
a meeting of Shareholders,  not less than 10 days prior to the date on which the
particular  action requiring such  determination of Shareholders is to be taken.
If the stock  transfer  books are not closed and no record date is fixed for the
determination  of Shareholders  entitled to notice of or to vote at a meeting of
Shareholders,  or Shareholders  entitled to receive  payment of a dividend,  the
close of business on the date on which notice of the meeting is mailed or on the
date on which the  resolution of the Board of Directors  declaring such dividend
is adopted,  as the case may be, shall be the record date for such determination
of Shareholders.  When a determination  of Shareholders  entitled to vote at any
meeting  of  Shareholders  has  been  made as  provided  in this  Section,  such
determination  shall be  applied to any  adjournment  thereof  except  where the
determination  has been made through the closing of the stock transfer books and
the stated period of closing has expired.

     SECTION 6. VOTING  RECORD.  The  Secretary  shall,  before each  meeting of
Shareholders,  make a complete list of the Shareholders entitled to vote at such
meeting,  or any  adjournment  thereof,  with the  address  of and the number of
shares held by each. Such record shall be produced and kept open at the time and
place of the meeting and shall be subject to the  inspection of any  Shareholder
during  the whole time of the  meeting  for the  purposes  of the  meeting.  The
original  stock  transfer  books shall be prima facie evidence as to who are the
Shareholders entitled to examine such record or transfer books or to vote at any
meeting of Shareholders. Failure to comply with the requirements of this Section
shall not affect the validity of any action taken at such meeting.

     SECTION 7. QUORUM.  Shares  entitled to vote as a separate  voting group as
defined in the Wisconsin Business Corporation Law may take action on a matter at
a meeting only if a quorum of those  shares  exists with respect to that matter.
Unless the Articles of Incorporation or the Wisconsin  Business  Corporation Law
provide otherwise,  a majority of the votes entitled to be cast on the matter by
a voting  group  constitutes  a quorum of that  voting  group for action on that
matter.

     Once a share is represented  for any purposes at a meeting,  other than for
the purpose of objecting to holding the meeting or  transacting  business at the
meeting,  it is considered present for purposes of determining  whether a quorum
exists for the remainder of the meeting and for any  adjournment of that meeting
unless a new record date is or must be set for that adjourned meeting.

     If a quorum exists, action on a matter by a voting group is approved if the
votes cast within the voting  group  favoring  the action  exceed the votes cast
opposing  the action,  unless the  Articles of  Incorporation  or the  Wisconsin
Business Corporation Law require a greater number of affirmative votes.

     "Voting group" means any of the following:

          A. All shares of one or more classes or series that under the Articles
     of Incorporation or the Wisconsin Business  Corporation Law are entitled to
     vote and be  counted  together  collectively  on a matter at a  meeting  of
     Shareholders.

          B.  All  shares  that  under  the  Articles  of  Incorporation  or the
     Wisconsin  Business  Corporation  Law are  entitled to vote  generally on a
     matter.

          Though less than a quorum of the outstanding shares are represented at
     a meeting,  a majority of the shares so represented may adjourn the meeting
     from time to time without  further  notice.  At such  adjourned  meeting at
     which a  quorum  shall be  present  or  represented,  any  business  may be
     transacted  which might have been  transacted  at the meeting as originally
     notified.

     SECTION 8. PROXIES. At all meetings of Shareholders, a Shareholder entitled
to vote may vote in person or by proxy.  A  Shareholder  may  appoint a proxy to
vote or otherwise act for the Shareholder by signing an appointment form, either
personally  or by  his  or  her  attorney-in-fact.  Such  proxy  appointment  is
effective  when  received by the Secretary of the  Corporation  before or at the
time of the meeting. Unless otherwise provided in the appointment form of proxy,
a proxy  appointment  may be revoked at any time  before it is voted,  either by
written  notice filed with the Secretary or the acting  Secretary of the meeting
or by oral notice given by the  Shareholder to the presiding  officer during the
meeting.  The  presence  of a  Shareholder  who  has  filed  his  or  her  proxy
appointment  shall not of itself  constitute a revocation.  No proxy appointment
shall be valid  after  eleven  months  from  the date of its  execution,  unless
otherwise  provided in the  appointment  form of proxy.  The Board of  Directors
shall have the power and authority to make rules establishing presumptions as to
the validity and sufficiency of proxy appointments.

     SECTION 9. VOTING OF SHARES.  Each  outstanding  share shall be entitled to
one vote upon each  matter  submitted  to a vote at a meeting  of  Shareholders,
except to the extent that the voting rights of the shares of any voting group or
groups are enlarged, limited or denied by the Articles of Incorporation.

     SECTION 10. VOTING OF SHARES BY CERTAIN HOLDERS.

          A.  OTHER  CORPORATIONS.  Shares  standing  in  the  name  of  another
     corporation  may be voted either in person or by proxy, by the president of
     such  corporation  or any other  officer  appointed by such  president.  An
     appointment  form of proxy executed by any principal  officer of such other
     corporation  or  assistant  thereto  shall be  conclusive  evidence  of the
     signer's  authority  to act,  in the  absence  of  express  notice  to this
     Corporation,  given in writing to the Secretary of this Corporation, or the
     designation of some other person by the Board of Directors or by the Bylaws
     of such other corporation.

          B.  LEGAL   REPRESENTATIVES   AND  FIDUCIARIES.   Shares  held  by  an
     administrator,  executor,  guardian,  conservator,  trustee in  bankruptcy,
     receiver or assignee for creditors may be voted by him, either in person or
     by proxy,  without a transfer of such shares into his or her name, provided
     that  there is filed  with the  Secretary  before or at the time of meeting
     proper  evidence of his or her  incumbency and the number of shares held by
     him, either in person or by proxy. An appointment form of proxy executed by
     a fiduciary shall be conclusive  evidence of the signer's authority to act,
     in the absence of express notice to this  Corporation,  given in writing to
     the  Secretary,  that such  manner of voting  is  expressly  prohibited  or
     otherwise directed by the document creating the fiduciary relationship.

          C. PLEDGEES.  A Shareholder whose shares are pledged shall be entitled
     to vote such shares until the shares have been transferred into the name of
     the  pledgee,  and  thereafter  the  pledgee  shall be entitled to vote the
     shares so transferred;  provided,  however,  a pledgee shall be entitled to
     vote  shares  held of record by the  pledgor  if the  Corporation  receives
     acceptable evidence of the pledgee's authority to sign.

          D. TREASURY  STOCK AND  SUBSIDIARIES.  Neither  treasury  shares,  nor
     shares held by another  corporation if a majority of the shares entitled to
     vote for the  election of directors  of such other  corporation  is held by
     this  Corporation,  shall be voted at any meeting or counted in determining
     the total number of outstanding  shares entitled to vote, but shares of its
     own issue held by this Corporation in a fiduciary capacity, or held by such
     other  corporation  in a  fiduciary  capacity,  may be voted  and  shall be
     counted in determining  the total number of outstanding  shares entitled to
     vote.

          E. MINORS. Shares held by a minor may be voted by such minor in person
     or by  proxy  and no  such  vote  shall  be  subject  to  disaffirmance  or
     avoidance,  unless prior to such vote the Secretary of the  Corporation has
     received  written notice or has actual knowledge that such Shareholder is a
     minor.  Shares  held by a minor may be voted by a personal  representative,
     administrator,  executor, guardian or conservator representing the minor if
     evidence  of such  fiduciary  status,  acceptable  to the  Corporation,  is
     presented.

          F.  INCOMPETENTS  AND  SPENDTHRIFTS.  Shares held by an incompetent or
     spendthrift may be voted by such incompetent or spendthrift in person or by
     proxy and no such vote  shall be  subject to  disaffirmance  or  avoidance,
     unless  prior to such vote the  Secretary  of the  Corporation  has  actual
     knowledge  that such  Shareholder  has been  adjudicated  an incompetent or
     spendthrift or actual knowledge of judicial  proceedings for appointment of
     a guardian.  Shares held by an incompetent or spendthrift may be voted by a
     personal representative,  administrator,  executor, guardian or conservator
     representing the minor if evidence of such fiduciary status,  acceptable to
     the Corporation, is presented.

          G.  JOINT  TENANTS.  Shares  registered  in the  names  of two or more
     individuals who are named in the registration as joint tenants may be voted
     in person  or by proxy  signed  by any one or more of such  individuals  if
     either (i) no other such individual or his or her legal  representative  is
     present and claims the right to participate in the voting of such shares or
     prior to the vote files with the  Secretary of the  Corporation  a contrary
     written voting authorization or direction or written denial of authority of
     the individual present or signing the appointment form of proxy proposed to
     be voted, or (ii) all such other individuals are deceased and the Secretary
     of the  Corporation  has no actual  knowledge  that the  survivor  has been
     adjudicated not to be the successor to the interests of those deceased.

     SECTION 11.  CONDUCT OF  MEETINGS.  The  Chairman  of the Board,  or in the
Chairman's absence,  the President,  or, in their absence such Vice President as
is designated by the Board of Directors, shall call the meeting to order and act
as Chairperson  of the meeting.  Only persons  nominated in accordance  with the
procedures set forth in Article II, Sections 1 and 2, shall be eligible to serve
as Directors.  Only such business as shall have been brought before a meeting in
accordance  with the procedures set forth in Article II, Sections 1 and 2, shall
be eligible to be conducted. The Chairperson of the meeting shall have the power
and duty to determine  whether any  nomination  or any  business  proposed to be
brought before the meeting was made in accordance  with the procedures set forth
in Article II, Sections 1 and 2, and, if any proposed  nomination or business is
not in compliance  therewith,  to declare that such defective  proposal shall be
disregarded.

     SECTION 12. PUBLIC ANNOUNCEMENT. For purposes of Article II, Sections 1 and
2, "public  announcement"  shall mean disclosure in a press release  reported by
the Dow Jones News  Service,  Associated  Press,  or  comparable  national  news
service or in a document  publicly filed by the Corporation  with the Securities
and Exchange  Commission  pursuant to Section 13, 14, or 15(d) of the Securities
Exchange Act of 1934, as amended.

     SECTION  13.  INVALIDITY.  The  Chairperson,  upon  recommendation  of  the
Secretary,  may reject a vote,  consent,  waiver, or proxy  appointment,  if the
Secretary or other  officer or agent of the  Corporation  who is  authorized  to
tabulate votes, acting in good faith, has reasonable doubt about the validity of
the  signature  on it or  about  the  signatory's  authority  to  sign  for  the
Shareholder.  The  Corporation and its officer or agent who accepts or rejects a
vote, consent,  waiver or proxy appointment in good faith and in accordance with
the Wisconsin  Business  Corporation  Law shall not be liable for damages to the
Shareholders for consequences of the acceptance or rejection.

     SECTION 14. WAIVER OF NOTICE.  A Shareholder  may waive any notice required
by the Wisconsin  Business  Corporation Law, the Articles of  Incorporation,  or
these Bylaws before or after the date and time stated in the notice.  The waiver
shall be in  writing  and  signed by the  Shareholder  entitled  to the  notice,
contain the same  information  that would have been required in the notice under
the  Wisconsin  Business  Corporation  Law  (except  that the time and  place of
meeting need not be stated),  and be delivered to the  Corporation for inclusion
in the corporate  records.  A Shareholder's  attendance at any Annual Meeting or
Special  Meeting,  in  person  or by  proxy,  waives  objection  to  all  of the
following:  (a) lack of notice or defective  notice of the  meeting,  unless the
Shareholder  promptly upon arrival or at the beginning of the meeting objects to
holding,  or transacting  business at, the meeting;  and (b)  consideration of a
particular matter at the meeting that is not within the purpose described in the
meeting notice, unless the Shareholder objects to considering the matter when it
is presented.

                         ARTICLE III. BOARD OF DIRECTORS

     SECTION  1.  NUMBER OF  DIRECTORS.  Within the  limits  established  in the
Articles of  Incorporation,  the number of Directors of the Corporation shall be
such number as shall be determined by the Board of Directors from time to time.

     SECTION 2. TERM OF OFFICE.  Elected  Directors shall hold office for a term
of three (3) years and until their successors are elected and qualified,  except
as  otherwise  provided in this  Section or until their  death,  resignation  or
removal. The Board of Directors shall be divided into three (3) classes of three
(3) or more  directors  each,  with,  as nearly as possible,  an equal number of
Directors  in each  class.  The term of office of the first  class of  Directors
shall expire at the first annual  meeting after their initial  election and when
their  successors  are elected and  qualified,  the term of office of the second
class shall expire at the second annual meeting after their initial election and
when their successors are elected and qualified,  and the terms of office of the
third  class  shall  expire at the third  annual  meeting  after  their  initial
election and when their  successors  are elected and  qualified.  At each annual
meeting after the initial classification of the Board of Directors, the class of
Directors  whose term expires at the time of such  election  shall be elected to
hold office until the third succeeding annual meeting and until their successors
are elected and qualified.

     SECTION 3. NOMINATIONS.  Nominations for the election of directors shall be
made in accordance  with the provisions of Article II,  Sections 1 and 2 hereof,
which  requirements  are hereby  incorporated  by reference in this Article III,
Section 3.

     SECTION 4. REGULAR  MEETINGS.  A regular  meeting of the Board of Directors
shall be held without other notice than this Bylaw immediately after, and at the
same place as, the Annual  Meeting of  Shareholders,  for  election of corporate
officers and transaction of other  business.  The Board of Directors may provide
by resolution the time and place for holding  additional  meetings without other
notice than such resolution.

     SECTION 5.  SPECIAL  MEETINGS.  Special  Meetings of the Board of Directors
shall be held whenever called by the Chairman of the Board or the Secretary upon
written  request of any three  Directors.  The Secretary  shall give  sufficient
notice of such  meeting,  to be not less than two (2) days, in person or by mail
or by  telephone,  telegraph,  teletype,  facsimile  or  other  form  of wire or
wireless  communication  as to enable the  Directors  so notified to attend such
meeting.  The  Chairman  or  Secretary  who calls the meeting may fix any place,
within or without the State of  Wisconsin,  as the place for holding any Special
Meeting of the Board of Directors.

     SECTION 6. WAIVER OF NOTICE.  Whenever any notice whatsoever is required to
be given to any Director of the Corporation  under the Articles of Incorporation
or Bylaws or any provisions of law, a waiver  thereof in writing,  signed at any
time,  whether before or after the time of meeting,  by the Director entitled to
such notice,  shall be deemed  equivalent to the giving of such notice,  and the
Corporation  shall retain  copies of such waivers in its  corporate  records.  A
director's  attendance  at or  participation  in a meeting  waives any  required
notice to him or her of the meeting  unless the Director at the beginning of the
meeting or promptly  upon his or her arrival  objects to holding the meeting and
does not thereafter  vote for or assent to action taken at the meeting.  Neither
the  business  to be  transacted  at, nor the purpose of, any regular or special
meeting of the Board of  Directors  need be specified in the notice or waiver of
notice of such meeting.

     SECTION 7.  QUORUM.  A  majority  of the  Directors  in office for the time
being, and convened according to these Bylaws, shall constitute a quorum for the
transaction   of  business,   but  a  majority  of  the  directors   present  or
participating  (though  less than a quorum) may adjourn the meeting from time to
time without further notice.

     SECTION 8. VACANCIES.  Vacancies, including those created by an increase in
the  number  of  directors  in the  Board of  Directors,  may be  filled  by the
remaining  Directors.  A Director  elected to fill a vacancy shall serve for the
unexpired  term of his or her  predecessor.  In the  absence  of  action  by the
remaining Directors, the Shareholders may fill such vacancy at a Special Meeting
in  accordance  with the  Articles of  Incorporation,  or by  unanimous  consent
according to these Bylaws.

     SECTION 9. REMOVAL. The Shareholders may remove one or more directors, with
or without  cause,  at a meeting  called for that  purpose,  the notice of which
reflects that purpose,  in accordance with the Articles of Incorporation of this
Corporation.

     SECTION 10.  COMPENSATION.  A director  may receive such  compensation  for
services  as is  determined  by  resolution  of the  Board  irrespective  of any
personal  interest of its members.  A director also may serve the Corporation in
any other capacity and receive  compensation  therefore.  The Board of Directors
also  shall  have  authority  to  provide  for or to  delegate  authority  to an
appropriate  committee to provide for reasonable  pensions,  disability or death
benefits and other  benefits or payments,  to Directors,  Officers and employees
and to their estates, families,  dependents or beneficiaries on account of prior
services rendered to the Corporation by such Directors, Officers and employees.

     SECTION 11. GENERAL POWERS.  All corporate  powers shall be exercised by or
under the authority of, and the business and affairs of the Corporation shall be
managed  under  the  direction  of,  the  Board  of  Directors,  subject  to any
limitation set forth in these Bylaws or the Articles of Incorporation.

     SECTION 12.  CONDUCT OF  MEETINGS.  The  Chairman  of the Board,  or in the
Chairman's absence the President,  or in their absence such Vice President as is
designated  by the  Board of  Directors,  shall  call  meetings  of the Board of
Directors to order and shall act as Chairperson of the meeting. The Secretary of
the  Corporation  shall  act as  Secretary  of all  meetings  of  the  Board  of
Directors,  but in the  absence of the  Secretary,  the  presiding  Officer  may
appoint an  Assistant  Secretary  or any  Director  or other  person  present or
participating to act as Secretary of the meeting.

     SECTION 13. MANNER OF ACTING. If a quorum is present or participating  when
a vote is taken,  the  affirmative  vote of a majority of  directors  present or
participating  is the act of the Board of  Directors or a committee of the Board
of Directors,  unless the Wisconsin Business  Corporation Law or the Articles of
Incorporation or these Bylaws require the vote of a greater number of directors.

     SECTION 14.  PRESUMPTION OF ASSENT.  A Director of the  Corporation  who is
present at or participates in a meeting of the Board of Directors or a committee
thereof which he or she is a member,  at which action on any corporate matter is
taken,  shall be presumed to have assented to the action taken unless his or her
dissent shall be entered in the minutes of the meeting or unless he or she shall
file his or her written  dissent to such  action  with the person  acting as the
Secretary of the meeting  before the  adjournment  thereof or shall forward such
dissent by registered mail to the Secretary of the Corporation immediately after
the  adjournment  of the  meeting.  Such right to  dissent  shall not apply to a
Director who voted in favor of such action.

     SECTION 15.  UNANIMOUS  CONSENT  WITHOUT  MEETING.  Any action  required or
permitted by the Articles of  Incorporation or Bylaws or any provision of law to
be taken by the Board of  Directors at a meeting or by  resolution  may be taken
without a meeting if a consent in  writing,  setting  forth the action so taken,
shall be signed by all of the Directors then in office.

     SECTION 16.  MEETING BY  TELEPHONE  OR BY OTHER  COMMUNICATION  TECHNOLOGY.
Meetings of the Board of Directors or  committees  may be conducted by telephone
or by other communication  technology in accordance with Section 180.0820 of the
Wisconsin Business Corporation Law.

     SECTION 17. COMMITTEES.

          A. REGULAR COMMITTEES.

               1. GENERAL  DESCRIPTION.  In order to facilitate  the work of the
          Board  of  Directors  of  this  Corporation,   the  following  regular
          committees  shall be  elected  from  the  membership  of the  Board of
          Directors at the regular  meeting held in May of each year (or at such
          other time as the Board of Directors may determine):

                               Executive Committee
                                Finance Committee
                             Compensation Committee
                                 Audit Committee

               Each committee shall consist of such number of members,  not less
          than three (3), as shall be determined by the Board of Directors.  The
          Chairman of the Board of Directors,  and in the Chairman's absence the
          President,  and in their absence, such Vice President as is designated
          by the Board of Directors, shall submit nominations for such committee
          memberships.  Committee members shall hold office until the next board
          meeting at which Committee  elections are conducted in accordance with
          these Bylaws,  and until their  successors  are elected and qualified.
          Each  Regular  Committee  of the Board of  Directors  may exercise the
          authority  of the full Board within the scope of the duties and powers
          delegated  to it in these  Bylaws,  except that no  committee  of this
          Board shall do any of the following:

                    (a) Authorize distributions;

                    (b)  Approve  or  propose to  shareholders  action  that the
               Wisconsin  Business  Corporation  Law  requires  be  approved  by
               shareholders;

                    (c) Fill  vacancies on the board of directors  or, except as
               provided herein, on any of its committees;

                    (d) Amend the Articles of Incorporation;

                    (e) Adopt, amend or repeal the Bylaws;

                    (f)  Approve  a plan of  merger  not  requiring  shareholder
               approval;

                    (g)  Authorize or approve  reacquisition  of shares,  except
               according to a formula or method prescribed by the full Board; or

                    (h)  Authorize  or approve the  issuance or sale or contract
               for sale of shares or  determine  the  designation  and  relative
               rights,  preferences  and  limitations  of a class or  series  of
               shares,  except  that the  Board of  Directors  may  authorize  a
               committee or a senior executive  officer of the Corporation to do
               so within limits prescribed by the Board of Directors.

               2. THE EXECUTIVE COMMITTEE. When the Board of Directors is not in
          session,  the Executive  Committee  shall have and may exercise all of
          the powers of the full Board solely with regard to those matters which
          are within the scope of the Executive  Committee's  designated duties,
          as provided herein.  The Chairman of the Board of Directors shall be a
          member of the Executive Committee.

               The Executive Committee shall:

                    (a)  Approve  long  range  corporate  and  strategic  plans,
               including  plans  for any  major  borrowing  or  capital  raising
               programs;

                    (b) Advise and consult with management on corporate policies
               regarding reserving, reinsurance and other liabilities;

                    (c) Approve the annual operating plan;

                    (d) Approve major  changes in policy  affecting new services
               and programs; and

                    (e)  Carry  out such  special  assignments  as the  Board of
               Directors  may,  from  time  to  time,   give  to  the  Executive
               Committee.

          3. THE  FINANCE  COMMITTEE.  When the  Board  of  Directors  is not in
     session,  the  Finance  Committee  shall have and may  exercise  all of the
     powers of the full Board  solely  with  regard to those  matters  which are
     within the scope of the Finance Committee's  designated duties, as provided
     herein.  The  Chairman of the Board of  Directors  shall be a member of the
     Finance Committee.

               The Finance Committee shall:

                    (a) Approve investment policies and plans;

                    (b)  Authorize  and approve the  investment  of funds of the
               Corporation;

                    (c) Consult with management regarding real estate,  accounts
               receivable and other assets;

                    (d)  Determine  the amount and types of all  insurance  that
               should be carried by this  Corporation and authorize the purchase
               thereof;

                    (e) Advise and consult with the operating  management in the
               selection of the carriers of such insurance;

                    (f) Advise and consult  with  management  on  corporate  tax
               policy; and

                    (g)  Carry  out such  special  assignments  as the  Board of
               Directors may, from time to time, give to the Finance Committee.

          4. THE COMPENSATION  COMMITTEE.  When the Board of Directors is not in
     session, the Compensation  Committee shall have and may exercise all of the
     powers of the full Board  solely  with  regard to those  matters  which are
     within the scope of the  Compensation  Committee's  designated  duties,  as
     provided herein.

               The Compensation Committee shall:

                    (a)  Evaluate   Senior   Management   (corporate   officers)
               performance against objectives;

                    (b) Approve Senior Management development programs;

                    (c) Approve the  corporate  compensation  policy,  including
               making  recommendations and decisions on any bonuses or incentive
               plans, and establish the annual  compensation for the Chairman of
               the Board of Directors;

                    (d)  Act  as  the  Nominating  Committee  for  officers  and
               directors  and  make  recommendations  to the  Board  for  types,
               methods and levels of directors' compensation;

                    (e)  Administer  the  compensation  plans for the  officers,
               directors, and key employees; and

                    (f)  Carry  out such  special  assignments  as the  Board of
               Directors  may,  from  time to  time,  give  to the  Compensation
               Committee.

               5. THE AUDIT  COMMITTEE.  When the Board of  Directors  is not in
          session,  the Audit  Committee  shall have and may exercise all of the
          powers of the full Board solely with regard to those matters which are
          within  the  scope of the  Audit  Committee's  designated  duties,  as
          provided herein.

               The Audit Committee shall:

                    (a)  Select  and engage  the  independent  certified  public
               accountants   to  audit  the   books,   records   and   financial
               transactions of the Corporation;

                    (b) Review  with the  independent  accountants  the scope of
               their examination, with particular emphasis on the areas to which
               either  the  committee  or the  independent  accountants  believe
               special  attention  should be directed.  The Audit  Committee may
               have  the   independent   accountants   perform  such  additional
               procedures as the Committee or the auditors deem necessary;

                    (c) Review and  approve  the annual  plan for the  financial
               audit (internal audit) department;

                    (d) Review with the  independent  accountants  the financial
               statements and auditors' reports thereon;

                    (e)  Review  the  management   letter  of  the   independent
               accountants,  and audit  reports  by the  Corporation's  internal
               auditors  to assure  that  appropriate  action  has been taken by
               Senior Management as to each item recommended;

                    (f) Encourage the  independent  accountants and the internal
               auditors to  communicate  directly with the Chairman of the Board
               and  President  or,  if  necessary,  the  Chairman  of the  Audit
               Committee  whenever any significant  recommendation  has not been
               satisfactorily resolved at the Senior Management level;

                    (g) Review the Conflict of Interest statements to assure the
               Board of  Directors  that any  conflict of interest has been duly
               reported to and reviewed by Audit Committee;

                    (h) Review and approve all related party transactions; and

                         (i) Carry out such special  assignments as the Board of
                    Directors  may,  from  time  to  time,  give  to  the  Audit
                    Committee.

          B.  SPECIAL   COMMITTEES.   In  addition  to  the  foregoing   Regular
     Committees,  the  Board of  Directors  may,  from  time to time,  establish
     Special Committees and specify the composition,  functions and authority of
     any such Special Committee.

          C. VACANCIES;  TEMPORARY  APPOINTMENTS.  When, for any cause a vacancy
     occurs in any  Regular  Committee,  the  remaining  committee  members,  by
     majority  vote,  may fill such  vacancy  by a  temporary  appointment  of a
     director  on the Board not on the  subject  committee  to fill the  vacancy
     until the next Board  Meeting,  at which time the full Board shall fill the
     vacancy.

          D.  COMMITTEE  MINUTES AND REPORTS.  All of the  foregoing  committees
     shall keep minutes and records of all of their  meetings and activities and
     shall  report  the same to the  Board  of  Directors  at its  next  regular
     meeting.  Such minutes and records shall be available for inspection by the
     Directors at all times.

                              ARTICLE IV. OFFICERS

     SECTION 1. GENERALLY.  The principal Officers of the Corporation shall be a
Chairman of the Board (Chief Executive Officer),  a President,  one or more Vice
Presidents,  a Secretary and a Treasurer. The Board of Directors shall elect the
principal  officers  annually at the Annual  Meeting.  All  officers  shall hold
office for a period of one year and until their  successors are duly elected and
qualified, or until their prior death, resignation or removal.

     SECTION  2.  REMOVAL.  Any  officer or agent may be removed by the Board of
Directors  with or without cause  whenever in its judgment the best interests of
the  Corporation  would be served  thereby,  but such  removal  shall be without
prejudice to the contract rights, if any, of the person so removed.  Election or
appointment shall not of itself create contract rights.

     SECTION 3. VACANCIES.  A vacancy in any principal  office because of death,
resignation,  removal,  or otherwise,  shall be filled by the Board of Directors
for the unexpired  portion of the term. The Board of Directors may, from time to
time, omit to elect one or more officers,  or may omit to fill a vacancy, and in
such case, the designated duties of such officer,  unless otherwise  provided in
these  Bylaws,  shall be  discharged  by the Chairman of the Board or such other
officers as he or she may designate.

     SECTION 4. CHAIRMAN OF THE BOARD. The Chairman of the Board, who shall also
be  the  Chief  Executive  Officer,   shall  preside  at  all  meetings  of  the
Shareholders  and of the Directors and shall do and perform such other duties as
from time to time may be assigned to that office by the Board of Directors.

     SECTION 5. PRESIDENT.  The President shall have general  supervision of the
business and affairs of the Corporation.  The President may sign and execute all
authorized bonds, notes, checks,  contracts, or other obligations in the name of
the  Corporation.  The President shall perform such other duties as from time to
time may be assigned to him or her by the Board of Directors.

     SECTION 6. VICE PRESIDENTS.  Should the Chairman or the President be absent
or unable to act, the Board of  Directors  shall  designate a Vice  President or
other  Officer to discharge  the duties of the vacant office with the same power
and  authority as is vested in that office.  The Vice  Presidents  shall perform
such other duties as from time to time may be assigned to them by the  President
or the Board of Directors.

     SECTION 7.  SECRETARY.  The Secretary shall keep a record of the minutes of
the meetings of the Shareholders and of the Board of Directors.  He or she shall
countersign all instruments and documents executed by the Corporation;  affix to
instruments and documents the seal of the  Corporation;  keep in books therefore
the  transactions  of the  Corporation;  see that all  notices are duly given in
accordance  with the  provisions  of these  Bylaws or as  required  by law;  and
perform  such other  duties as usually  are  incident  to such  office or may be
assigned by the Chairman of the Board, the President or the Board of Directors.

     SECTION 8. TREASURER. The Treasurer, subject to the control of the Board of
Directors,  shall  collect,  receive,  and  safely  keep all  monies,  funds and
securities of the Corporation,  and attend to all its pecuniary  affairs.  He or
she shall keep full and complete  accounts and records of all its  transactions,
of sums owing to or by the Corporation, and all rents and profits in its behalf.

     SECTION 9. ASSISTANTS AND ACTING  OFFICERS.  The Chairman of the Board, the
President and the Board of Directors  shall have the power to appoint any person
to act as  assistant  to any  officer,  or as agent for the  Corporation  in the
officer's  stead,  or to perform  the duties of such  officer  whenever  for any
reason it is impracticable for the officer to act personally,  and the assistant
or acting officer or other agent so appointed by the Chairman of the Board,  the
President  or the Board of  Directors  shall have the power to  perform  all the
duties of the office to which he or she is so appointed to be  assistant,  or as
to which he or she is so appointed to act, except as such power otherwise may be
defined or restricted  by the Chairman of the Board,  the President or the Board
of Directors.

     SECTION 10. SALARIES. The salaries of the principal officers shall be fixed
from time to time by the Board of  Directors or by a duly  authorized  committee
thereof,  and no officer shall be prevented from receiving such salary by reason
of the fact that he or she is also a Director of the Corporation.

                       ARTICLE V. FUNDS OF THE CORPORATION

     SECTION  1.  FUNDS.  All funds of the  Corporation  shall be  deposited  or
invested in such  depositories  or in such  securities as may be authorized from
time  to  time  by  the  Board  of  Directors  or  appropriate  committee  under
authorization of the Board of Directors.

     SECTION 2. NAME. All  investments  and deposits of funds of the Corporation
shall be made and held in its corporate name,  except that securities kept under
a  custodial  agreement  or trust  arrangement  with a bank or banking and trust
company may be issued in the name of a nominee of such bank or banking and trust
company and except that securities may be acquired and held in bearer form.

     SECTION 3. LOANS. All loans contracted on behalf of the Corporation and all
evidences of indebtedness  that are issued in the name of the Corporation  shall
be  under  the  authority  of a  resolution  of the  Board  of  Directors.  Such
authorization may be general or specific.

     SECTION 4.  CONTRACTS.  The Board of Directors  may  authorize  one or more
officers,  or agents,  to enter into any  contract  or execute  and  deliver any
instrument in the name of and on behalf of the Corporation.  Such  authorization
may be general or  specific.  In the  absence of other  designation,  all deeds,
mortgages and instruments of assignment or pledge made by the Corporation  shall
be executed in the name of the  Corporation  by the  Chairman of the Board,  the
President or one of the Vice  Presidents and by the Secretary or Treasurer;  the
Secretary,  when necessary or required,  shall affix the corporate seal thereto;
and when so executed no other party to such  instrument or any third party shall
be required to make any inquiry  into the  authority  of the signing  officer or
officers.

     SECTION 5. DISBURSEMENTS.  All monies of the Corporation shall be disbursed
by check,  draft,  or  written  order  only,  and all  checks and orders for the
payment  of  money  shall  be  signed  by such  Officer  or  Officers  as may be
designated  by the  Board  of  Directors.  The  Officers  and  employees  of the
Corporation  handling funds and securities of the corporation  shall give surety
bonds in such  sums as the  Board of  Directors  or  appropriate  committee  may
require.

     SECTION  6.  PROHIBITED  TRANSACTIONS.  No  directors  or  Officer  of  the
Corporation shall borrow money from the Corporation, or receive any compensation
for selling,  aiding in the sale,  or  negotiating  for the sale of any property
belonging  to  the  Corporation,  or  for  negotiating  any  loan  for or by the
Corporation.

     SECTION 7. VOTING OF SECURITIES OWNED BY THIS  CORPORATION.  Subject always
to the specific directions of the Board of Directors:

          A. Any shares or other securities  issued by any other corporation and
     owned or  controlled  by this  Corporation  may be voted at any  meeting of
     security  holders of such other  corporation  by the Chairman of the Board,
     the  President or in their absence any Vice  President of this  Corporation
     who may be present and designated by the Board of Directors; and

          B.  Whenever,  in the  judgment  of the  Chairman  of the  Board,  the
     President,  or  in  their  absence,  a  designated  Vice  President,  it is
     desirable  for this  Corporation  to execute a proxy or written  consent in
     respect to any shares or other securities  issued by any other  corporation
     and owned by this  Corporation,  such proxy or consent shall be executed in
     the name of this  Corporation by the Chairman of the Board,  the President,
     or a designated Vice President of this Corporation in the order as provided
     in clause A. of this Section, without necessity of any authorization by the
     Board of Directors,  affixation of corporate  seal or  countersignature  or
     attestation  by another  officer.  Any person or persons  designated in the
     manner above stated as the proxy or proxies of this Corporation  shall have
     full  right,  power and  authority  to vote the shares or other  securities
     issued by such other  corporation and owned by this Corporation the same as
     such shares or other securities might be voted by this Corporation.

             ARTICLE VI. CERTIFICATES FOR SHARES AND THEIR TRANSFER

     SECTION 1. CERTIFICATES FOR SHARES. Certificates representing shares of the
Corporation  shall be in such form,  consistent with law, as shall be determined
by the Board of Directors.  Such Certificates shall be signed by the Chairman of
the Board, the President, or a Vice President,  and the Secretary, or by another
officer  designated by the Chairman of the Board,  the President or the Board of
Directors.  All  certificates  for shares  shall be  consecutively  numbered  or
otherwise  identified.  The name and  address  of the  person to whom the shares
represented  thereby  are  issued,  with the number of shares and date of issue,
shall  be  entered  on  the  stock  transfer  books  of  the  Corporation.   All
certificates  surrendered to the  Corporation for transfer shall be canceled and
no new  certificate  shall be issued  until the  former  certificate  for a like
number of shares shall have been surrendered and canceled, except as provided in
Section 6 of this Article VI.

     SECTION 2. FACSIMILE  SIGNATURES  AND SEAL. The seal of the  Corporation on
any certificates for shares may be a facsimile. The signature of the Chairman of
the Board, the President or other authorized officer upon a certificate may be a
facsimile if the  certificate is manually  signed on behalf of a transfer agent,
or a  registrar,  other  than  the  Corporation  itself  or an  employee  of the
Corporation.

     SECTION 3. SIGNATURE BY FORMER OFFICER.  In case any officer who has signed
or whose  facsimile  signature has been placed upon any  certificate  for shares
shall have ceased to be such officer before such  certificate is issued,  it may
be  issued  by the  Corporation  with the same  effect as if he or she were such
officer at the date of its issue.

     SECTION 4. TRANSFER OF SHARES.  Prior to due  presentment  of a certificate
for  shares  for  registration  of  transfer,  the  Corporation  may  treat  the
shareholder  of such  shares as the  person  exclusively  entitled  to vote,  to
receive  notifications  and  otherwise  to have and  exercise all the rights and
powers  of an  owner.  Where  a  certificate  for  shares  is  presented  to the
Corporation with a request to register for transfer,  the Corporation  shall not
be liable to the owner or any other  person  suffering  loss as a result of such
registration of transfer if:

          A. There were on or with the certificate  the necessary  endorsements;
     and

          B. The  Corporation  had no duty to inquire into adverse claims or has
     discharged any such duty.

     The Corporation may require reasonable assurance that said endorsements are
genuine and effective and in compliance  with such other  regulations  as may be
prescribed by or under the authority of the Board of Directors:

     SECTION 5.  RESTRICTIONS  ON  TRANSFER.  The face or  reverse  side of each
certificate  representing  shares  shall  bear  a  conspicuous  notation  of any
restriction imposed by the Corporation upon the transfer of such shares.

     SECTION 6. LOST, DESTROYED OR STOLEN  CERTIFICATES.  Where the owner claims
that his or her  certificate  for shares has been lost,  destroyed or wrongfully
taken, a new certificate shall be issued in place thereof if the owner:

          A. So requests before the Corporation has notice that such shares have
     been acquired by a bona fide purchaser;

          B. Files with the Corporation a sufficient indemnity bond; and

          C. Satisfies such other  reasonable  requirements as may be prescribed
     by or under the authority of the Board of Directors.

     SECTION 7.  CONSIDERATION FOR SHARES.  The shares of the Corporation may be
issued for such  consideration  as shall be fixed from time to time by the Board
of  Directors,  provided  that any shares having a par value shall not be issued
for a consideration  less than the par value thereof.  The  consideration  to be
received  for shares may  consist of any  tangible  or  intangible  property  or
benefit  to  the  Corporation,   including  cash,   promissory  notes,  services
performed,  contracts  for services to be performed or other  securities  of the
Corporation. When the Corporation receives the consideration for which the Board
of  Directors  authorized  the  issuance of shares,  the shares  issued for that
consideration  are fully paid and  nonassessable,  except as provided by Section
180.0622 of the Wisconsin  Business  Corporation  Law which may require  further
assessment  for unpaid  wages to  employees  under  certain  circumstances.  The
Corporation may place in escrow shares issued for a contract for future services
or benefits or a promissory  note,  or make other  arrangements  to restrict the
transfer of the shares,  and may credit  distributions  in respect of the shares
against their purchase price, until the services are performed, the benefits are
received or the note is paid.  If the services are not  performed,  the benefits
are not received or the note is not paid, the Corporation  may cancel,  in whole
or in part, the shares escrowed or restricted and the distributions credited.

     SECTION 8.  UNCERTIFICATED  SHARES.  In accordance with Section 180.0626 of
the  Wisconsin  Business  Corporation  Law, the Board of Directors may issue any
shares of any of its classes or series without  certificates.  The authorization
does  not  affect  shares  already   represented  by   certificates   until  the
certificates are surrendered to the Corporation.  Within a reasonable time after
the issuance or transfer of shares without  certificates,  the Corporation shall
send the Shareholder a written  statement of the  information  required on share
certificates by Sections 180.0625 and 180.0627, if applicable,  of the Wisconsin
Business Corporation Law, and by the Bylaws of the Corporation.

     The  Corporation  shall  maintain at its  offices,  or at the office of its
transfer  agent,  an original or duplicate  stock  transfer book  containing the
names and  addresses of all  Shareholders  and the number of shares held by each
Shareholder. If the shares are uncertificated, the Corporation shall be entitled
to recognize the exclusive right of a person registered on its books as such, as
the owner of shares for all  purposes,  and shall not be bound to recognize  any
equitable  or other claim to or interest in such shares on the part of any other
person, whether or not it shall have express or other notice thereof,  except as
otherwise provided by the laws of the State of Wisconsin.

     SECTION 9. TRANSFER AGENT AND REGISTRAR.  The  Corporation may maintain one
or more  transfer  offices  or  agencies,  each in  charge of a  transfer  agent
designated  by the  Board  of  Directors,  where  the  shares  of  stock  of the
Corporation shall be transferable. The Corporation also may maintain one or more
registry  offices,  each in charge  of a  registrar  designated  by the Board of
Directors,  where such shares of stock shall be  registered.  The same person or
entity may be both a transfer agent and registrar.

     SECTION 10. STOCK REGULATIONS.  The Board of Directors shall have the power
and authority to make all such further rules and  regulations  not  inconsistent
with the laws of the State of Wisconsin as it may deem expedient  concerning the
issue,  transfer and  registration  of certificates  representing  shares of the
Corporation.

                  ARTICLE VII. INDEMNIFICATION AND LIABILITY OF
                             OFFICERS AND DIRECTORS

     SECTION 1. INDEMNIFICATION.

          A. Any person,  or such  person's  estate or personal  representative,
     made  or  threatened  with  being  made  a  party  to  any  action,   suit,
     arbitration,   or   proceeding   (civil,   criminal,   administrative,   or
     investigative,   whether  formal  or  informal),  which  involves  foreign,
     federal,  state or local law,  by reason of the fact that such person is or
     was a Director  or Officer of this  Corporation  or of any  corporation  or
     other enterprise for which he or she served at this  Corporation's  request
     as a director,  officer,  partner,  trustee,  member of any decision-making
     committee, employee, or agent, shall be indemnified by this Corporation for
     all reasonable  expenses incurred in the proceeding to the extent he or she
     has been successful on the merits or otherwise.

          B.  In  cases  where  a  person  described  in  subsection  A.  is not
     successful on the merits or otherwise,  this  Corporation  shall  indemnify
     such person against  liability and reasonable  expenses  incurred by him or
     her in any such  proceeding,  unless  liability  was  incurred  because the
     person  breached  or  failed  to  perform  a  duty  he or she  owed  to the
     Corporation  and the breach or failure  to perform  constituted  any of the
     following:

               1. A willful  failure to deal fairly with the  Corporation or its
          Shareholders  in  connection  with a matter in which the  Director  or
          Officer had a material conflict of interest;

               2. A violation  of criminal  law,  unless the Director or Officer
          had  reasonable  cause to believe  his or her conduct was lawful or no
          reasonable cause to believe his or her conduct was unlawful;

               3. A  transaction  from which the Director or Officer  derived an
          improper personal profit; or

               4. Willful misconduct.

          C. The determination  whether  indemnification shall be required under
     subsection  B. shall be made,  at the selection of the Director or Officer,
     according to one of the following methods:

               1. By a  majority  vote of a quorum  of the  Board  of  Directors
          consisting of directors not at the time parties to the same or related
          proceedings.   If  a  quorum  of  disinterested  directors  cannot  be
          obtained,  by majority vote of a committee duly appointed by the Board
          of Directors and consisting solely of two or more directors not at the
          time  parties to the same or related  proceedings.  Directors  who are
          parties  to the same or related  proceedings  may  participate  in the
          designation of members of the committee;

               2. By independent legal counsel selected by a quorum of the Board
          of Directors or its committee in the manner  prescribed in sub. 1. or,
          if unable to obtain such a quorum or committee,  by a majority vote of
          the full Board of  Directors,  including  Directors who are parties to
          the same or related proceedings; or

               3. By the court  conducting  the  proceedings or another court of
          competent  jurisdiction,  either on  application  by the  Director  or
          Officer for an initial  determination  or on application for review of
          an adverse determination under 1. or 2. above.

          D. The termination of a proceeding by judgment,  order,  settlement or
     conviction,  or upon a plea of no contest or an equivalent  plea, does not,
     by itself,  create a presumption  that  indemnification  of the Director or
     Officer is not required.

          E. A Director or Officer who seeks  indemnification under this Section
     shall make a written request to the Corporation.

          F. Upon  written  request by a Director or Officer who is a party to a
     proceeding  described  in  subsection  A.,  this  Corporation  may  pay  or
     reimburse  his or her  reasonable  expenses as incurred if the  Director or
     Officer provides the Corporation with all of the following:

               1. A written  affirmation of his or her good faith belief that he
          or she has not  breached or failed to perform his or her duties to the
          Corporation; and

               2. A written  undertaking,  executed  personally or on his or her
          behalf, to repay the allowance,  and reasonable  interest thereon,  to
          the extent that it is ultimately determined under subsections C. 1. or
          C. 2., above,  that  indemnification  is not required or to the extent
          that indemnification is not ordered by a court under subsection C. 3.,
          above.  The undertaking  under this  subsection  shall be an unlimited
          general obligation of the Director or Officer, may be accepted without
          reference  to his or her  ability to repay the  allowance,  and may be
          secured or unsecured.

          G. This Article VII,  Section 1  subsections  A.-F.,  shall also apply
     where a person, or such person's estate or personal representative, is made
     or  threatened  with  being  made a party to any  proceeding  described  in
     subsection  A. by reason of the fact that such person is or was an Employee
     of the  Corporation,  except that in addition to the  categories of conduct
     set forth in subsection B. in relation to which the Corporation has no duty
     to  indemnify,  the  Corporation  also shall have no duty to indemnify  the
     Employee against  liability and reasonable  expenses incurred by him or her
     in any such  proceeding  if  liability  was  incurred  because  the  person
     breached or failed to perform a duty he or she owed to the  Corporation and
     the  breach or  failure  to  perform  constituted  material  negligence  or
     material  misconduct  in  performance  of  the  Employee's  duties  to  the
     Corporation.

          H. Unless a Director or Officer of this Corporation has knowledge that
     makes reliance  unwarranted,  a Director or Officer,  in discharging his or
     her duties to the Corporation,  may rely on information,  opinions, reports
     or  statements,  any of which may be written or oral,  formal or  informal,
     including  financial  statements and other  financial  data, if prepared or
     presented by any of the following:

               1. An officer or employee of the Corporation whom the Director or
          Officer  believes in good faith to be reliable  and  competent  in the
          matters presented;

               2.  Legal  counsel,  public  accountants  or other  persons as to
          matters the Director or Officer  believes in good faith are within the
          person's professional or expert competence; or

               3. In the case of  reliance by a  Director,  a  committee  of the
          Board  of  Directors  of which  the  Director  is not a member  if the
          Director believes in good faith that the committee merits confidence.

               This subsection does not apply to the liability of a Director for
          improper declaration of dividends,  distribution of assets,  corporate
          purchase of its own shares,  or distribution of assets to shareholders
          during  liquidation,  or for  corporate  loans  made to an  Officer or
          Director,   under   Wisconsin   Business   Corporation   Law   Section
          180.0832(1),  or the reliance of a Director on  financial  information
          represented  as  correct  by  corporate  officers  or  independent  or
          certified public accountants under Wisconsin Business  Corporation Law
          Section 180.0826.

          I.  In  discharging  his  or her  duties  to  the  Corporation  and in
     determining  what he or she  believes  to be in the  best  interest  of the
     Corporation,  a Director or Officer  may, in  addition to  considering  the
     effects of any action on Shareholders, consider the following:

               1.  The  effects  of  the  action  on  employees,  suppliers  and
          customers of the Corporation;

               2.  The  effects  of the  action  on  communities  in  which  the
          Corporation operates; or

               3. Any other factor the Director or Officer considers pertinent.

     SECTION 2. LIMITED  LIABILITY OF DIRECTORS AND OFFICERS TO CORPORATION  AND
SHAREHOLDERS.

          A. Except as provided in  subsection  B. of this Section 2, a Director
     or Officer  is not liable to this  Corporation,  its  Shareholders,  or any
     person asserting  rights on behalf of the Corporation or its  Shareholders,
     for  damages,  settlements,   fees,  fines,  penalties  or  other  monetary
     liabilities  arising  from a breach  of, or failure  to  perform,  any duty
     resulting  solely from his or her status as a  Director,  unless the person
     asserting   liability   proves  that  the  breach  or  failure  to  perform
     constitutes any of the following:

               1.  A  willful  failure  to  deal  with  the  Corporation  or its
          Shareholders  in connection  with a matter in which the Director had a
          material conflict of interest;

               2. A violation  of criminal  law,  unless the Director or Officer
          had  reasonable  cause to believe  his or her conduct was lawful or no
          reasonable cause to believe his or her conduct was unlawful;

               3. A  transaction  from which the  Director  derived an  improper
          personal profit; or

               4. Willful misconduct.

          B. This  Section 2 does not apply to the  liability  of a Director  or
     Officer for improper  declaration  of  dividends,  distribution  of assets,
     corporate  purchase  of its  own  shares,  or  distribution  of  assets  to
     shareholders during liquidation,  or for corporate loans made to an Officer
     or Director, under Wisconsin Business Corporation Law Section 180.0832(1).

     SECTION 3. CODE OF ETHICS.

          A.  Directors,  Officers and management  employees  shall exercise the
     utmost good faith in all  transactions  touching  upon their  duties to the
     Corporation  and its property.  In their dealings with and on behalf of the
     Corporation  they are held to a strict  rule of  honesty  and fair  dealing
     between themselves and the Corporation. They shall not use their positions,
     or knowledge  gained  therefrom,  so that a conflict may arise  between the
     Corporation's interest and that of the individual.

          A "conflict  of interest"  transaction  means a  transaction  with the
     Corporation in which a Director of the Corporation has a direct or indirect
     interest.  The  circumstances in which a Director of the Corporation has an
     indirect  interest  in a  transaction  include  but  are not  limited  to a
     transaction under any of the following circumstances:

               1. Another entity in which the Director has a material  financial
          interest or in which the  Director is a general  partner is a party to
          the transaction; or

               2. Another entity of which the Director is a director, officer or
          trustee  is a party to the  transaction  and the  transaction  is,  or
          because of its significance to the Corporation  should be,  considered
          material by the Board of Directors of the  Corporation.  A conflict of
          interest transaction is not voidable by the Corporation solely because
          of  the  Director's   interest  in  the  transaction  if  any  of  the
          circumstances set forth in Section 180.0831 of the Wisconsin  Business
          Corporation Law are true or occur.

          B. All acts of Directors,  Officers and management  employees shall be
     for the sole benefit of the  Corporation in any dealing which may affect it
     adversely.

          C. No Director,  Officer or management employee shall accept any favor
     which might  influence  his  official  act or which might  reflect upon his
     business conduct.

          D. Officers and management employees shall avoid outside employment or
     activity  which  involves  obligations  which  may  compete  with  or be in
     conflict with the interests of the Corporation.

          E. A full disclosure of all facts of any transaction  which is subject
     to any doubt shall be made to the Chairman of the Board or the President of
     the Corporation before consummating the same.

          F. A copy of this Article VII,  Section 3, annually shall be delivered
     to all  Directors,  Officers and management  employees,  each of whom shall
     acknowledge receipt thereof to the Secretary of the Corporation.

                        ARTICLE VIII. CORPORATE DIVIDENDS

     The Board of  Directors  may from  time to time  declare  dividends  on its
outstanding  shares in the manner and upon the terms and conditions  provided by
law and its Articles of Incorporation.

                           ARTICLE IX. CORPORATE SEAL

     The Board of Directors  may provide a corporate  seal which may be circular
in form and may have inscribed thereon the name of the Corporation and the state
of incorporation and the words "Corporate Seal."

                             ARTICLE X. FISCAL YEAR

     The fiscal year shall be set by the Board of Directors.

                             ARTICLE XI. AMENDMENTS

     SECTION  1. BY  SHAREHOLDERS.  These  Bylaws  may be  altered,  amended  or
repealed and new Bylaws may be adopted by the  Shareholders by affirmative  vote
of not less than a majority of the shares present or represented at an annual or
special meeting of the Shareholders at which a quorum is in attendance.

     SECTION  2. BY  DIRECTORS.  These  Bylaws may also be  altered,  amended or
repealed and new Bylaws may be adopted by the Board of Directors by  affirmative
vote of a majority of the number of Directors present at or participating in any
meeting  at  which a  quorum  is in  attendance;  but no  bylaw  adopted  by the
Shareholders shall be amended or repealed by the Board of Directors if the bylaw
so adopted so provides.

     SECTION 3.  IMPLIED  AMENDMENTS.  Any  action  taken or  authorized  by the
Shareholders or by the Board of Directors,  which would be inconsistent with the
Bylaws then in effect but is taken or authorized by affirmative vote of not less
than the  number of shares or the  number  of  Directors  required  to amend the
Bylaws so that the Bylaws would be consistent  with such action,  shall be given
the same effect as though the Bylaws had been  temporarily  amended or suspended
so far, but only so far, as is necessary to permit the specific  action so taken
or authorized.


                                                                    EXHIBIT 99.2

                                  [Letterhead]

NEWS RELEASE
For Immediate Release
                                               
                                                   For more information contact:
                                                                    Cliff Bowers
                                                                  Vice-President
                                                        Corporate Communications
                                                                   (920)661-2766


                     NEW YORK STOCK EXCHANGE TRADING BEGINS
                  ON SHARES OF AMERICAN MEDICAL SECURITY GROUP

     GREEN BAY, Wis. -- Sept. 29, 1998 -- Shares of the  reconstituted  American
Medical Security Group,  Inc. (ticker AMZ), were officially traded for the first
time yesterday on the New York Stock Exchange.

     The beginning of trading in American  Medical  Security Group (AMSG) common
shares  follows  the  completion  last week of the  company's  spinoff of United
Wisconsin Services, Inc.

                                 AMS BACKGROUND

     The  continuing  operations  of AMSG  consist of the  individual  and small
employer group health business of American Medical Security Holdings,  Inc., and
its operating  subsidiaries  (AMS). AMS health care benefit policies are sold by
independent  agents in 33 states and the  District  of  Columbia.  Approximately
578,000 individuals in the U.S. are covered by the company's policies.

     The Green Bay, Wis.-based company  specializes in providing  cost-effective
managed  care  for the  small  business  market.  AMS,  with  1997  revenues  of
approximately  $1 billion,  offers a full  complement  of health care  services:
medical, dental, prescription drug, life insurance and disability.

                                   - Ad One -
      
     According to the U.S. Department of Census, the small business market where
AMS  has  significant  expertise  is the  fastest-growing  segment  of the  U.S.
economy. The segment currently accounts for 21 million businesses, 68 percent of
all new U.S. jobs and 57 percent of the nation's private workforce.

     Most AMS health care benefits are provided through PPO (Preferred  Provider
Organization)  plans. PPO plans differ from HMO plans in that they often provide
a wider choice of health professionals, fewer benefit restrictions and increased
access to  specialists  at a  somewhat  higher  price than  HMOs.  Medical  plan
enrollment has grown faster in PPOs than in HMOs in recent years.  At the end of
1997,  35 percent of the nation's  employees was covered by PPO health plans and
30 percent was enrolled in HMO plans.

     In addition to its nearly 578,000 medical members, AMS has approximately
                             411,000 dental members
                                 2,000 employees
                              70 U.S. sales offices
                            38,000 independent agents

     AMS owns two  provider  networks  through  which  nearly a  quarter  of its
business is conducted.  It also leases networks to ensure cost efficient  health
care choices for its customers. Other alliances include:
                                 7,000 hospitals
                            400,000 medical providers
                                50,000 pharmacies

                                   AMS HISTORY

     AMS  was  founded  in  1988 as a joint  venture  between  United  Wisconsin
Services and two health care industry entrepreneurs. AMS grew rapidly until 1995
and  1996  when it  experienced  significant  operating  losses.  In  1996,  UWS
exercised its option to purchase the  remainder of AMS. At that time,  Samuel V.
Miller was named President & Chief Operating Officer.

                                   - Ad Two -

     Miller  initiated a far-reaching  turnaround  strategy that returned AMS to
profitability  in  1997.  Improved  health-loss  and  health-expense  ratios,  a
restructured sales and marketing strategy, and a new senior management team were
central components of the turnaround.

                             CURRENT AMS MANAGEMENT

     SAMUEL V. MILLER -- CHAIRMAN, PRESIDENT & CHIEF EXECUTIVE OFFICER

     Prior to joining AMS,  Miller was a member of the Executive  Staff Planning
Group with  Travelers  Group in New York. In that capacity he served as Chairman
and Group  Chief  Executive  of  National  Benefit  Life  Insurance  Company and
Primerica Financial Services Ltd. of Canada.
     
     He was also one of the  builders of Employers  Health,  now the small group
business  of  Humana,  where he  worked  as  Senior  Vice  President  of Sales &
Marketing. He later took on additional responsibility as Chief Operating Officer
and led the company's sale to American Express in 1982.

     Miller  moved  to  American  Express  Life in 1984  and  presided  over the
building of the largest long-term-care business in America. He was also a member
of the  Senior  Management  Committee  at  American  Express in New York and was
President & CEO of American Express Life.

     Within  the first 12  months of  becoming  President  & CEO of AMS,  Miller
assembled a new team of executive  officers with  significant  professional  and
industry  experience.  Those executives  include Edward R. Skoldberg,  Executive
Vice President & Chief Operating  Officer;  Gary D.  Guengerich,  Executive Vice
President  &  Chief  Financial  Officer;  and  Timothy  J.  Moore,  Senior  Vice
President, General Counsel and Corporate Secretary.

     Last week the AMSG board of directors elected Miller Chairman,  President &
CEO of the  company.  Skoldberg,  Guengerich  and Moore have been elected to the
same offices with AMSG they previously held with AMS.

                                  - Ad Three -

                                OVERALL STRATEGY

     The  central  company   objective  is  to  build  a  multi-billion   dollar
corporation   that  is  the  nation's   foremost   small  group,   managed  care
organization. It will do so by expanding sales through independent agents and by
continuing to reduce loss and expense ratios.

     In addition, AMSG will continue to leverage its expense ratio advantage and
its expertise in the small group  segment to acquire books of business  during a
period  of  industry  consolidation.   In  September  1997,  AMS  purchased  the
individual and small group business of Pan-American Life Insurance  Company.  It
acquired much of  Pan-American's  remaining  domestic health benefit business in
July 1998.

                                    # # # # #

     CAUTIONARY STATEMENT: This release contains forward-looking statements with
respect to the  financial  condition,  results of  operations  and  business  of
American  Medical  Security  Group,  Inc. Such  forward-looking  statements  are
subject to inherent  risks and  uncertainties  that may cause actual  results or
events to differ  materially  from those  contemplated  by such  forward-looking
statements. Factors that may cause actual results or events to differ materially
from those contemplated  include rising health care costs,  business  conditions
and competition in the managed care industry, developments in health care reform
and other  regulatory  issues and other  factors  that may be referred to in the
Company's reports filed with the Securities and Exchange Commission from time to
time.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission